{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:12:22Z","timestamp":1794514342434,"version":"4.9.1"},"reference-count":621,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4S1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is intended to assist health care professionals worldwide who evaluate and manage potential candidates for deceased or living donor kidney transplantation. This guideline addresses general candidacy issues such as access to transplantation, patient demographic and health status factors, and immunological and psychosocial assessment. The roles of various risk factors and comorbid conditions governing an individual\u2019s suitability for transplantation such as adherence, tobacco use, diabetes, obesity, perioperative issues, causes of kidney failure, infections, malignancy, pulmonary disease, cardiac and peripheral arterial disease, neurologic disease, gastrointestinal and liver disease, hematologic disease, and bone and mineral disorder are also addressed. This guideline provides recommendations for evaluation of individual aspects of a candidate\u2019s profile such that each risk factor and comorbidity are considered separately. The goal is to assist the clinical team to assimilate all data relevant to an individual, consider this within their local health context, and make an overall judgment on candidacy for transplantation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. Guideline recommendations are primarily based on systematic reviews of relevant studies and our assessment of the quality of that evidence, and the strengths of recommendations are provided. Limitations of the evidence are discussed with differences from previous guidelines noted and suggestions for future research are also provided.<\/jats:p>","DOI":"10.1097\/tp.0000000000003136","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T14:49:29Z","timestamp":1586184569000},"page":"S11-S103","source":"Crossref","is-referenced-by-count":687,"title":["KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation"],"prefix":"10.1097","volume":"104","author":[{"given":"Steven J.","family":"Chadban","sequence":"first","affiliation":[{"name":"Royal Prince Alfred Hospital and Charles Perkins Centre, University of Sydney, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curie","family":"Ahn","sequence":"additional","affiliation":[{"name":"Seoul National University, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Axelrod","sequence":"additional","affiliation":[{"name":"University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany J.","family":"Foster","sequence":"additional","affiliation":[{"name":"The Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram L.","family":"Kasiske","sequence":"additional","affiliation":[{"name":"Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijah","family":"Kher","sequence":"additional","affiliation":[{"name":"Medanta Kidney and Urology Institute, Haryana, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Kumar","sequence":"additional","affiliation":[{"name":"University Health Network, University of Toronto, Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Oberbauer","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[{"name":"Hospital del Mar, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Pilmore","sequence":"additional","affiliation":[{"name":"Auckland City Hospital, Auckland, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Rodrigue","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.","family":"Sheerin","sequence":"additional","affiliation":[{"name":"Newcastle University, Newcastle, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Tinckam","sequence":"additional","affiliation":[{"name":"University Health Network, University of Toronto, Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Knoll","sequence":"additional","affiliation":[{"name":"The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ki.2008.388","article-title":"The Declaration of Istanbul on organ trafficking and transplant tourism.","volume":"74","year":"2008","journal-title":"Kidney Int"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes.","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"key":"R3-20231002","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations.","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/sj.ki.5001875","article-title":"A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"70","author":"Uhlig","year":"2006","journal-title":"Kidney Int"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-139-6-200309160-00013","article-title":"Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization.","volume":"139","author":"Shiffman","year":"2003","journal-title":"Ann Intern Med"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/ndt\/gfq780","article-title":"Cost-effectiveness analysis of renal replacement therapy in Austria.","volume":"26","author":"Haller","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrneph.2014.145","article-title":"Economic evaluation of dialysis therapies.","volume":"10","author":"Klarenbach","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation.","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"e29591","DOI":"10.1371\/journal.pone.0029591","article-title":"Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities.","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/ajt.13095","article-title":"Individual and regional factors of access to the renal transplant waiting list in france in a cohort of dialyzed patients.","volume":"15","author":"Bayat","year":"2015","journal-title":"Am J Transplant"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.ajkd.2016.08.038","article-title":"Referral for Kidney Transplantation and Indicators of Quality of Dialysis Care: A Cross-sectional Study.","volume":"69","author":"Plantinga","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1681\/ASN.2013070784","article-title":"New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes.","volume":"25","author":"Israni","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/TP.0000000000001057","article-title":"Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States.","volume":"100","author":"Smith","year":"2016","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"R23-20231002","doi-asserted-by":"crossref","first-page":"c209","DOI":"10.1159\/000328070","article-title":"Renal Association Clinical Practice Guideline on the assessment of the potential kidney transplant recipient.","volume":"118","author":"Dudley","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1503\/cmaj.091661","article-title":"Predicting potential survival benefit of renal transplantation in patients with chronic kidney disease.","volume":"182","author":"van Walraven","year":"2010","journal-title":"CMAJ"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/TP.0000000000001326","article-title":"Predictive Score for Posttransplantation Outcomes.","volume":"101","author":"Molnar","year":"2017","journal-title":"Transplantation"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/TP.0000000000001019","article-title":"iChoose Kidney: A Clinical Decision Aid for Kidney Transplantation Versus Dialysis Treatment.","volume":"100","author":"Patzer","year":"2016","journal-title":"Transplantation"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/nep.12068","article-title":"KHA-CARI guideline: recipient assessment for transplantation.","volume":"18","author":"Campbell","year":"2013","journal-title":"Nephrology (Carlton)"},{"issue":"Suppl 2","key":"R28-20231002","first-page":"3","article-title":"The evaluation of renal transplantation candidates: clinical practice guidelines.","volume":"1","author":"Kasiske","year":"2001","journal-title":"Am J Transplant"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1503\/cmaj.1041588","article-title":"Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.","volume":"173","author":"Knoll","year":"2005","journal-title":"CMAJ"},{"issue":"Suppl 3","key":"R30-20231002","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients.","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/ndt\/gfr169","article-title":"Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement.","volume":"26","author":"Heemann","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e3181ac620b","article-title":"A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index.","volume":"88","author":"Rao","year":"2009","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"R33-20231002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.13666","article-title":"Kidney.","volume":"16","author":"Hart","year":"2016","journal-title":"Am J Transplant"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/ndt\/gfq826","article-title":"Deceased donor transplantation in the elderly--are we creating false hope?","volume":"26","author":"Stevens","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R35-20231002","first-page":"188","article-title":"Renal transplantation in elderly patients.","volume":"28","author":"Ponticelli","year":"2014","journal-title":"How to select the candidates to the waiting list? Transplant Rev"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archsurg.2011.1229","article-title":"Frailty and delayed graft function in kidney transplant recipients.","volume":"147","author":"Garonzik-Wang","year":"2012","journal-title":"Arch Surg"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/01.TP.0000438026.03958.7b","article-title":"Recipient age and risk for mortality after kidney transplantation in England.","volume":"97","author":"Karim","year":"2014","journal-title":"Transplantation"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1111\/j.1600-6143.2012.04285.x","article-title":"Early hospital readmission after kidney transplantation: patient and center-level associations.","volume":"12","author":"McAdams-Demarco","year":"2012","journal-title":"Am J Transplant"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1097\/TP.0000000000001546","article-title":"Individual Frailty Components and Mortality in Kidney Transplant Recipients.","volume":"101","author":"McAdams-DeMarco","year":"2017","journal-title":"Transplantation"},{"key":"R40-20231002","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/jgs.13130","article-title":"Trends in kidney transplant outcomes in older adults.","volume":"62","author":"McAdams-DeMarco","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"R41-20231002","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1600-6143.2012.04323.x","article-title":"Quantification of the early risk of death in elderly kidney transplant recipients.","volume":"13","author":"Gill","year":"2013","journal-title":"Am J Transplant"},{"key":"R42-20231002","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/TP.0000000000000474","article-title":"A paired survival analysis comparing hemodialysis and kidney transplantation from deceased elderly donors older than 65 years.","volume":"99","author":"Lloveras","year":"2015","journal-title":"Transplantation"},{"key":"R43-20231002","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11255-004-0010-6","article-title":"Live and deceased donor kidney transplantation in patients aged 75 years and older in the United States.","volume":"37","author":"Macrae","year":"2005","journal-title":"Int Urol Nephrol"},{"key":"R44-20231002","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1111\/ajt.12830","article-title":"Survival benefit of primary deceased donor transplantation with high-KDPI kidneys.","volume":"14","author":"Massie","year":"2014","journal-title":"Am J Transplant"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1001\/jama.294.21.2726","article-title":"Deceased-donor characteristics and the survival benefit of kidney transplantation.","volume":"294","author":"Merion","year":"2005","journal-title":"JAMA"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1681\/ASN.V123589","article-title":"Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates.","volume":"12","author":"Ojo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/ajt.13800","article-title":"Survival Benefit From Kidney Transplantation Using Kidneys From Deceased Donors Aged \u2265 75 Years: A Time-Dependent Analysis.","volume":"16","author":"Perez-Saez","year":"2016","journal-title":"Am J Transplant"},{"key":"R48-20231002","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/01.tp.0000259621.56861.31","article-title":"Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients.","volume":"83","author":"Rao","year":"2007","journal-title":"Transplantation"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/01.tp.0000295988.28127.dd","article-title":"Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60 years and over.","volume":"84","author":"Savoye","year":"2007","journal-title":"Transplantation"},{"key":"R50-20231002","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1600-6143.2006.01390.x","article-title":"The expanded criteria donor policy: an evaluation of program objectives and indirect ramifications.","volume":"6","author":"Schold","year":"2006","journal-title":"Am J Transplant"},{"key":"R51-20231002","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R52-20231002","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.tp.0000251780.01031.81","article-title":"Early mortality rates in older kidney recipients with comorbid risk factors.","volume":"83","author":"Kauffman","year":"2007","journal-title":"Transplantation"},{"key":"R53-20231002","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/ctr.12463","article-title":"Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era.","volume":"28","author":"Al-Shraideh","year":"2014","journal-title":"Clin Transplant"},{"key":"R54-20231002","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.transproceed.2005.09.130","article-title":"Elderly donor kidney transplant: factors involved in graft survival.","volume":"37","author":"Cacho","year":"2005","journal-title":"Transplant Proc"},{"key":"R55-20231002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ndt\/gfh506","article-title":"Expanding the donor pool to increase renal transplantation.","volume":"20","author":"Cohen","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R56-20231002","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/01.ASN.0000120370.35927.40","article-title":"Patient and graft survival in older kidney transplant recipients: does age matter?","volume":"15","author":"Fabrizii","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R57-20231002","first-page":"101","article-title":"Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.","author":"Foley","year":"2005","journal-title":"Clin Transplant"},{"key":"R58-20231002","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1016\/j.transproceed.2005.09.009","article-title":"Should kidneys from older cadaveric donors be age-matched to the recipient?","volume":"37","author":"Foss","year":"2005","journal-title":"Transplant Proc"},{"key":"R59-20231002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-6143.2007.02014.x","article-title":"Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program.","volume":"8","author":"Frei","year":"2008","journal-title":"Am J Transplant"},{"key":"R60-20231002","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/TP.0b013e31819cdddd","article-title":"Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity.","volume":"87","author":"Heldal","year":"2009","journal-title":"Transplantation"},{"key":"R61-20231002","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/TP.0b013e3181f5c3bf","article-title":"Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN\/UNOS database.","volume":"90","author":"Huang","year":"2010","journal-title":"Transplantation"},{"key":"R62-20231002","first-page":"69","article-title":"Graft and quality of life outcomes in older recipients of a kidney transplant.","volume":"1","author":"Humar","year":"2003","journal-title":"Exp Clin Transplant"},{"key":"R63-20231002","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2215\/CJN.03760415","article-title":"Mortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria Donors.","volume":"11","author":"Ma","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R64-20231002","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1600-6143.2005.00923.x","article-title":"Kidneys from deceased donors: maximizing the value of a scarce resource.","volume":"5","author":"Meier-Kriesche","year":"2005","journal-title":"Am J Transplant"},{"key":"R65-20231002","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2215\/CJN.00150112","article-title":"Differential outcomes of expanded-criteria donor renal allografts according to recipient age.","volume":"7","author":"Mezrich","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R66-20231002","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/j.ajkd.2011.12.014","article-title":"Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes.","volume":"59","author":"Molnar","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R67-20231002","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1034\/j.1600-6143.2003.00111.x","article-title":"Improved scoring system to assess adult donors for cadaver renal transplantation.","volume":"3","author":"Nyberg","year":"2003","journal-title":"Am J Transplant"},{"key":"R68-20231002","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1681\/ASN.2014080771","article-title":"A Lifetime of Allograft Function with Kidneys from Older Donors.","volume":"26","author":"Rose","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R69-20231002","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1399-0012.2008.00881.x","article-title":"The evolving notion of \u201csenior\u201d kidney transplant recipients.","volume":"22","author":"Shah","year":"2008","journal-title":"Clin Transplant"},{"key":"R70-20231002","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1034\/j.1600-6143.2002.20713.x","article-title":"Evaluation of the Eurotransplant Senior Program. The results of the first year.","volume":"2","author":"Smits","year":"2002","journal-title":"Am J Transplant"},{"key":"R71-20231002","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/TP.0b013e3181e36dee","article-title":"Is it appropriate to implant kidneys from elderly donors in young recipients?","volume":"90","author":"Sola","year":"2010","journal-title":"Transplantation"},{"key":"R72-20231002","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/SLA.0b013e3181f65c7d","article-title":"The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome.","volume":"252","author":"Tullius","year":"2010","journal-title":"Ann Surg"},{"key":"R73-20231002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-6143.2002.020112.x","article-title":"Effect of donor factors on early graft survival in adult cadaveric renal transplantation.","volume":"2","author":"Swanson","year":"2002","journal-title":"Am J Transplant"},{"key":"R74-20231002","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2215\/CJN.02270409","article-title":"The alphabet soup of kidney transplantation: SCD, DCD, ECD--fundamentals for the practicing nephrologist.","volume":"4","author":"Rao","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R75-20231002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2215\/CJN.04120416","article-title":"Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study.","volume":"12","author":"Haller","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R76-20231002","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1600-6143.2007.01742.x","article-title":"Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys.","volume":"7","author":"Miles","year":"2007","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"R77-20231002","first-page":"ii1","article-title":"ERBP Guideline on the Management and Evaluation of the Kidney Donor and Recipient.","volume":"28","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R78-20231002","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mrdd.20116","article-title":"Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors.","volume":"12","author":"Gerson","year":"2006","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R79-20231002","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/petr.12389","article-title":"Intellectual and academic performance in children undergoing solid organ pretransplant evaluation.","volume":"19","author":"Reed-Knight","year":"2015","journal-title":"Pediatr Transplant"},{"key":"R80-20231002","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/ndt\/gfr650","article-title":"Neuropsychological profile of children with kidney transplants.","volume":"27","author":"Haavisto","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R81-20231002","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1399-3046.2010.01359.x","article-title":"Cognitive improvement in children with CKD after transplant.","volume":"14","author":"Icard","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R82-20231002","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.transproceed.2013.08.105","article-title":"Neurocognitive functions in pediatric renal transplant patients.","volume":"45","author":"Gulleroglu","year":"2013","journal-title":"Transplant Proc"},{"key":"R83-20231002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1523-1755.1999.00539.x","article-title":"Improvement in specific aspects of neurocognitive performance in children after renal transplantation.","volume":"56","author":"Mendley","year":"1999","journal-title":"Kidney Int"},{"key":"R84-20231002","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00467-013-2458-z","article-title":"Long-term neurocognitive outcomes of patients with end-stage renal disease during infancy.","volume":"28","author":"Johnson","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R85-20231002","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1037\/0022-006X.70.3.771","article-title":"Psychological assessment and care of organ transplant patients.","volume":"70","author":"Olbrisch","year":"2002","journal-title":"J Consult Clin Psychol"},{"key":"R86-20231002","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0033-3182(93)71865-4","article-title":"Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation.","volume":"34","author":"Levenson","year":"1993","journal-title":"Psychosomatics"},{"key":"R87-20231002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/152692480001000408","article-title":"Psychosocial assessments and outcomes in organ transplantation.","volume":"10","author":"Dew","year":"2000","journal-title":"Prog Transplant"},{"issue":"Suppl 7","key":"R88-20231002","first-page":"1","article-title":"European Best Practice Guidelines for Renal Transplantation (part 1).","volume":"15","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R89-20231002","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1503\/cmaj.051291","article-title":"Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation.","volume":"173","author":"Knoll","year":"2005","journal-title":"CMAJ"},{"key":"R91-20231002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/TP.0b013e3182637078","article-title":"Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable?","volume":"94","author":"Batabyal","year":"2012","journal-title":"Transplantation"},{"key":"R92-20231002","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/TP.0000000000001367","article-title":"Criteria for and Appropriateness of Renal Transplantation in Elderly Patients With End-Stage Renal Disease: A Literature Review and Position Statement on Behalf of the European Renal Association-European Dialysis and Transplant Association Descartes Working Group and European Renal Best Practice.","volume":"100","author":"Segall","year":"2016","journal-title":"Transplantation"},{"key":"R93-20231002","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/152692480101100208","article-title":"Psychosocial and behavioral selection criteria for solid organ transplantation.","volume":"11","author":"Dobbels","year":"2001","journal-title":"Prog Transplant"},{"key":"R94-20231002","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/YCO.0000000000000185","article-title":"Psychiatric aspects of organ transplantation and donation.","volume":"28","author":"Faeder","year":"2015","journal-title":"Curr Opin Psychiatry"},{"key":"R95-20231002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10880-015-9435-6","article-title":"Psychosocial Challenges in Solid Organ Transplantation.","volume":"22","author":"Kuntz","year":"2015","journal-title":"J Clin Psychol Med Settings"},{"key":"R96-20231002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psym.2011.12.012","article-title":"The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates.","volume":"53","author":"Maldonado","year":"2012","journal-title":"Psychosomatics"},{"key":"R97-20231002","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/PSY.0000000000000241","article-title":"The Stanford Integrated Psychosocial Assessment for Transplantation: A Prospective Study of Medical and Psychosocial Outcomes.","volume":"77","author":"Maldonado","year":"2015","journal-title":"Psychosom Med"},{"key":"R98-20231002","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1399-3046.2011.01620.x","article-title":"Psychosocial Assessment Tool 2.0_General: validity of a psychosocial risk screener in a pediatric kidney transplant sample.","volume":"16","author":"Pai","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R99-20231002","first-page":"164","article-title":"The PACT: A rating scale for the study of clinical decision-making in psychosocial screening of organ transplant candidates.","volume":"6","author":"Olbrisch","year":"1989","journal-title":"Clin Transplant"},{"key":"R100-20231002","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1176\/appi.psy.41.5.393","article-title":"The Structured Interview for Renal Transplantation--SIRT.","volume":"41","author":"Mori","year":"2000","journal-title":"Psychosomatics"},{"key":"R101-20231002","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0033-3182(93)71905-2","article-title":"The Transplant Evaluation Rating Scale. A revision of the psychosocial levels system for evaluating organ transplant candidates.","volume":"34","author":"Twillman","year":"1993","journal-title":"Psychosomatics"},{"key":"R102-20231002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/00981389.2013.764378","article-title":"Description of a psychosocial assessment instrument and risk criteria to support social work recommendations for kidney transplant candidates.","volume":"52","author":"Greene","year":"2013","journal-title":"Soc Work Health Care"},{"key":"R103-20231002","doi-asserted-by":"crossref","first-page":"822","DOI":"10.18549\/PharmPract.2016.04.822","article-title":"Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?","volume":"14","author":"Michaud","year":"2016","journal-title":"Pharm Pract (Granada)"},{"key":"R104-20231002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.TP.0000438212.72960.ae","article-title":"Depression and kidney transplantation.","volume":"97","author":"Chilcot","year":"2014","journal-title":"Transplantation"},{"key":"R105-20231002","doi-asserted-by":"crossref","first-page":"e0140706","DOI":"10.1371\/journal.pone.0140706","article-title":"Depression, Anxiety, Resilience and Coping Pre and Post Kidney Transplantation - Initial Findings from the Psychiatric Impairments in Kidney Transplantation (PI-KT)-Study.","volume":"10","author":"Muller","year":"2015","journal-title":"PLoS One"},{"key":"R106-20231002","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-244X-11-182","article-title":"Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: a prospective cohort study.","volume":"11","author":"Corruble","year":"2011","journal-title":"BMC Psychiatry"},{"key":"R107-20231002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10880-011-9249-0","article-title":"Psychological distress in patients presenting for initial renal transplant evaluation.","volume":"18","author":"Kuntz","year":"2011","journal-title":"J Clin Psychol Med Settings"},{"key":"R108-20231002","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/TP.0000000000001362","article-title":"Mental Health and Behavioral Barriers in Access to Kidney Transplantation: A Canadian Cohort Study.","volume":"101","author":"Mucsi","year":"2017","journal-title":"Transplantation"},{"key":"R109-20231002","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/TP.0000000000000901","article-title":"Depression and Anxiety as Risk Factors for Morbidity and Mortality After Organ Transplantation: A Systematic Review and Meta-Analysis.","volume":"100","author":"Dew","year":"2015","journal-title":"Transplantation"},{"key":"R110-20231002","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00007890-200009150-00001","article-title":"Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview.","volume":"70","author":"Bunzel","year":"2000","journal-title":"Transplantation"},{"key":"R111-20231002","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/TP.0b013e31829584e0","article-title":"Mental health disorders and solid-organ transplant recipients.","volume":"96","author":"Corbett","year":"2013","journal-title":"Transplantation"},{"key":"R112-20231002","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.transproceed.2011.01.158","article-title":"Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study.","volume":"43","author":"Calia","year":"2011","journal-title":"Transplant Proc"},{"key":"R113-20231002","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.ajkd.2008.01.010","article-title":"Depressive disorder in renal transplantation: an analysis of Medicare claims.","volume":"51","author":"Dobbels","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R114-20231002","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MOT.0b013e3283510928","article-title":"Psychiatric disorders as risk factors for adverse medical outcomes after solid organ transplantation.","volume":"17","author":"Rosenberger","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"R115-20231002","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/TP.0b013e31829f7579","article-title":"Alcohol and substance abuse in solid-organ transplant recipients.","volume":"96","author":"Parker","year":"2013","journal-title":"Transplantation"},{"key":"R116-20231002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000377685","article-title":"Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation.","volume":"41","author":"Lentine","year":"2015","journal-title":"Am J Nephrol"},{"key":"R117-20231002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/TP.0000000000000248","article-title":"Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data.","volume":"99","author":"Lentine","year":"2015","journal-title":"Transplantation"},{"key":"R118-20231002","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/ndt\/gfr445","article-title":"Social adaptability index predicts kidney transplant outcome: a single-center retrospective analysis.","volume":"27","author":"Garg","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R119-20231002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/lt.21278","article-title":"Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs.","volume":"14","author":"Dew","year":"2008","journal-title":"Liver Transpl"},{"key":"R121-20231002","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/TP.0b013e3181a440ae","article-title":"Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening.","volume":"87","author":"Dobbels","year":"2009","journal-title":"Transplantation"},{"key":"R123-20231002","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1111\/j.1600-6143.2009.02798.x","article-title":"Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression.","volume":"9","author":"Pinsky","year":"2009","journal-title":"Am J Transplant"},{"key":"R124-20231002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1399-3046.2011.01633.x","article-title":"Should we retransplant a patient who is non-adherent? A literature review and critical reflection.","volume":"16","author":"Dobbels","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R125-20231002","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/tri.12312","article-title":"Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study.","volume":"27","author":"De Geest","year":"2014","journal-title":"Transpl Int"},{"key":"R126-20231002","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1471-2458-11-386","article-title":"Community Preferences for the Allocation & Donation of Organs--the PAraDOx Study.","volume":"11","author":"Howard","year":"2011","journal-title":"BMC Public Health"},{"key":"R127-20231002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ctr.12004","article-title":"Rationing scarce organs for transplantation: healthcare provider perspectives on wait-listing and organ allocation.","volume":"27","author":"Tong","year":"2013","journal-title":"Clin Transplant"},{"key":"R128-20231002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2369-13-18","article-title":"Patient preferences for the allocation of deceased donor kidneys for transplantation: a mixed methods study.","volume":"13","author":"Tong","year":"2012","journal-title":"BMC Nephrol"},{"key":"R129-20231002","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.transproceed.2013.12.051","article-title":"Evaluation of non-adherence in patients undergoing dialysis and kidney transplantation: United States transplantation practice patterns survey.","volume":"46","author":"Brar","year":"2014","journal-title":"Transplant Proc"},{"key":"R130-20231002","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/ajt.13341","article-title":"The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival.","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"R131-20231002","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1600-6143.2009.02625.x","article-title":"Selective retransplant after graft loss to nonadherence: success with a second chance.","volume":"9","author":"Dunn","year":"2009","journal-title":"Am J Transplant"},{"key":"R132-20231002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1196\/annals.1440.010","article-title":"The adolescent brain.","volume":"1124","author":"Casey","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R133-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1529-1006.2006.00026.x","article-title":"Risk and Rationality in Adolescent Decision Making: Implications for Theory, Practice, and Public Policy.","volume":"7","author":"Reyna","year":"2006","journal-title":"Psychol Sci Public Interest"},{"key":"R134-20231002","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/13154","article-title":"In vivo evidence for post-adolescent brain maturation in frontal and striatal regions.","volume":"2","author":"Sowell","year":"1999","journal-title":"Nat Neurosci"},{"key":"R135-20231002","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/TP.0b013e31823411d7","article-title":"Association between age and graft failure rates in young kidney transplant recipients.","volume":"92","author":"Foster","year":"2011","journal-title":"Transplantation"},{"key":"R136-20231002","first-page":"CD002294","article-title":"Interventions for preoperative smoking cessation.","author":"Thomsen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R137-20231002","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1097\/TP.0000000000001335","article-title":"Correlates and Outcomes of Posttransplant Smoking in Solid Organ Transplant Recipients: A Systematic Literature Review and Meta-Analysis.","volume":"100","author":"Duerinckx","year":"2016","journal-title":"Transplantation"},{"key":"R138-20231002","first-page":"141","article-title":"Impact of cigarette smoking on kidney transplant recipients: a systematic review.","volume":"5","author":"Nourbala","year":"2011","journal-title":"Iran J Kidney Dis"},{"key":"R139-20231002","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/TP.0b013e318263ad5b","article-title":"Tobacco smoking and solid organ transplantation.","volume":"94","author":"Corbett","year":"2012","journal-title":"Transplantation"},{"key":"R140-20231002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.amepre.2012.02.013","article-title":"Efficacy of smoking-cessation interventions for young adults: a meta-analysis.","volume":"42","author":"Suls","year":"2012","journal-title":"Am J Prev Med"},{"key":"R141-20231002","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.115.002458","article-title":"Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.","volume":"10","author":"Suissa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R142-20231002","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"R143-20231002","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ndt\/gfu216","article-title":"European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.","volume":"30","author":"Abramowicz","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R144-20231002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging.","volume":"1","author":"Mitnitski","year":"2001","journal-title":"Scientific World Journal"},{"key":"R145-20231002","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s11255-016-1306-z","article-title":"High prevalence of frailty in end-stage renal disease.","volume":"48","author":"Drost","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"R147-20231002","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1600-6143.2006.01629.x","article-title":"A \u201cweight-listing\u201d paradox for candidates of renal transplantation?","volume":"7","author":"Schold","year":"2007","journal-title":"Am J Transplant"},{"key":"R148-20231002","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1600-6143.2011.03468.x","article-title":"Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.","volume":"11","author":"Molnar","year":"2011","journal-title":"Am J Transplant"},{"key":"R149-20231002","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ajt.12331","article-title":"The survival benefit of kidney transplantation in obese patients.","volume":"13","author":"Gill","year":"2013","journal-title":"Am J Transplant"},{"key":"R150-20231002","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/ajt.13363","article-title":"Kidney Transplantation Significantly Improves Patient and Graft Survival Irrespective of BMI: A Cohort Study.","volume":"15","author":"Krishnan","year":"2015","journal-title":"Am J Transplant"},{"key":"R151-20231002","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/ajt.12078","article-title":"Minimally invasive robotic kidney transplantation for obese patients previously denied access to transplantation.","volume":"13","author":"Oberholzer","year":"2013","journal-title":"Am J Transplant"},{"key":"R152-20231002","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.surg.2015.12.001","article-title":"Impact of panniculectomy on transplant candidacy of obese patients with chronic kidney disease declined for kidney transplantation because of a high-risk abdominal panniculus: A pilot study.","volume":"159","author":"Troppmann","year":"2016","journal-title":"Surgery"},{"key":"R153-20231002","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/jgs.12266","article-title":"Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis.","volume":"61","author":"McAdams-DeMarco","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"R154-20231002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/ajt.12992","article-title":"Frailty and mortality in kidney transplant recipients.","volume":"15","author":"McAdams-DeMarco","year":"2015","journal-title":"Am J Transplant"},{"key":"R155-20231002","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00345-016-1971-7","article-title":"Risk factors of severe incisional hernia after renal transplantation: a retrospective multicentric case-control study on 225 patients.","volume":"35","author":"Broggi","year":"2017","journal-title":"World J Urol"},{"key":"R156-20231002","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.surg.2015.11.017","article-title":"Incidence, risk factors, and treatment of incisional hernia after kidney transplantation: An analysis of 1,564 consecutive patients.","volume":"159","author":"Ooms","year":"2016","journal-title":"Surgery"},{"key":"R157-20231002","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00464-014-3682-8","article-title":"Incidence and risk factors of incisional hernia formation following abdominal organ transplantation.","volume":"29","author":"Smith","year":"2015","journal-title":"Surg Endosc"},{"key":"R158-20231002","doi-asserted-by":"crossref","first-page":"e1036","DOI":"10.1097\/GOX.0000000000001036","article-title":"Collagenopathies-Implications for Abdominal Wall Reconstruction: A Systematic Review.","volume":"4","author":"Harrison","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R159-20231002","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis.","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R160-20231002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2016.07.118","article-title":"Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?","volume":"222","author":"Garg","year":"2016","journal-title":"Int J Cardiol"},{"key":"R161-20231002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2047-1440-2-4","article-title":"Blood transfusion in deceased donor kidney transplantation.","volume":"2","author":"Marzouk","year":"2013","journal-title":"Transplant Res"},{"key":"R162-20231002","first-page":"1781684","article-title":"Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians.","author":"Peacock","year":"2016","journal-title":"Emerg Med Int"},{"key":"R163-20231002","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.transproceed.2010.04.064","article-title":"Third and fourth kidney transplant: still a reasonable option.","volume":"42","author":"Izquierdo","year":"2010","journal-title":"Transplant Proc"},{"key":"R164-20231002","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2215\/CJN.01780216","article-title":"Lower Extremity Permanent Dialysis Vascular Access.","volume":"11","author":"Parekh","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R165-20231002","doi-asserted-by":"crossref","first-page":"e0155481","DOI":"10.1371\/journal.pone.0155481","article-title":"Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease.","volume":"11","author":"Veroux","year":"2016","journal-title":"PLoS One"},{"key":"R166-20231002","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/TXD.0000000000000554","article-title":"Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease.","volume":"1","author":"Chebib","year":"2015","journal-title":"Transplant Direct"},{"key":"R167-20231002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/TP.0000000000000838","article-title":"Live Donor Renal Transplant With Simultaneous Bilateral Nephrectomy for Autosomal Dominant Polycystic Kidney Disease Is Feasible and Satisfactory at Long-term Follow-up.","volume":"100","author":"Ahmad","year":"2016","journal-title":"Transplantation"},{"key":"R168-20231002","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00007890-199810150-00001","article-title":"Successful transplantation of adult-sized kidneys into infants requires maintenance of high aortic blood flow.","volume":"66","author":"Salvatierra","year":"1998","journal-title":"Transplantation"},{"key":"R169-20231002","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00467-012-2115-y","article-title":"Native nephrectomy prior to pediatric kidney transplantation: biological and clinical aspects.","volume":"27","author":"Ghane Sharbaf","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R170-20231002","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s00467-006-0085-7","article-title":"Persistent post-transplant polyuria managed by bilateral native-kidney laparoscopic nephrectomy.","volume":"21","author":"Kravarusic","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R171-20231002","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0022-3476(80)80678-0","article-title":"Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria.","volume":"96","author":"Lau","year":"1980","journal-title":"J Pediatr"},{"key":"R172-20231002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ndt\/17.suppl_4.55","article-title":"IV.11 Paediatrics (specific problems).","volume":"17","author":"Cochat","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R173-20231002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ki.2014.154","article-title":"Is it time to increase access to transplantation for those with diabetic end-stage kidney disease?","volume":"86","author":"Chadban","year":"2014","journal-title":"Kidney Int"},{"key":"R174-20231002","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ki.2014.70","article-title":"Enhanced posttransplant management of patients with diabetes improves patient outcomes.","volume":"86","author":"Keddis","year":"2014","journal-title":"Kidney Int"},{"key":"R175-20231002","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/ndt\/17.9.1678","article-title":"Kidney transplantation in type 2 diabetic patients: a comparison with matched non-diabetic subjects.","volume":"17","author":"Boucek","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R176-20231002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S2213-8587(16)30317-5","article-title":"Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study.","volume":"5","author":"Lim","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R177-20231002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1600-6143.2011.03855.x","article-title":"New-onset diabetes after kidney transplantation-changes and challenges.","volume":"12","author":"Yates","year":"2012","journal-title":"Am J Transplant"},{"key":"R178-20231002","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2215\/CJN.04681107","article-title":"Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival.","volume":"3","author":"Cole","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R179-20231002","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"key":"R180-20231002","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"R181-20231002","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1681\/ASN.2011080835","article-title":"Early basal insulin therapy decreases new-onset diabetes after renal transplantation.","volume":"23","author":"Hecking","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R182-20231002","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0b013e31820f0877","article-title":"Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test.","volume":"91","author":"Caillard","year":"2011","journal-title":"Transplantation"},{"key":"R183-20231002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ndt\/18.1.164","article-title":"Post-transplant hyperglycaemia: a study of risk factors.","volume":"18","author":"Mathew","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R184-20231002","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.diabres.2013.12.049","article-title":"The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after kidney transplantation.","volume":"103","author":"Tokodai","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"R185-20231002","first-page":"140","article-title":"Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation.","volume":"71","author":"Ramesh Prasad","year":"2009","journal-title":"Clin Nephrol"},{"key":"R186-20231002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2215\/CJN.00090605","article-title":"Should an oral glucose tolerance test be performed routinely in all renal transplant recipients?","volume":"1","author":"Armstrong","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R187-20231002","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/TP.0b013e3181af1f53","article-title":"Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.","volume":"88","author":"Valderhaug","year":"2009","journal-title":"Transplantation"},{"key":"R188-20231002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.2010010031","article-title":"Diagnostic application of the A(1c) assay in renal disease.","volume":"21","author":"Sharif","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R189-20231002","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/TP.0000000000000376","article-title":"Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus.","volume":"99","author":"Eide","year":"2015","journal-title":"Transplantation"},{"key":"R190-20231002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis.","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"key":"R191-20231002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2017.03.015","article-title":"Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.","volume":"92","author":"Allen","year":"2017","journal-title":"Kidney Int"},{"key":"R192-20231002","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1038\/s41598-018-27151-4","article-title":"Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed\/advanced glomerulonephritis or unknown cause.","volume":"8","author":"Lim","year":"2018","journal-title":"Sci Rep"},{"key":"R193-20231002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.kint.2016.08.030","article-title":"Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation.","volume":"91","author":"Cosio","year":"2017","journal-title":"Kidney Int"},{"key":"R194-20231002","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00007890-199111000-00014","article-title":"Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects.","volume":"52","author":"Dantal","year":"1991","journal-title":"Transplantation"},{"key":"R195-20231002","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00007890-199102000-00025","article-title":"Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience.","volume":"51","author":"Ingulli","year":"1991","journal-title":"Transplantation"},{"key":"R196-20231002","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/TP.0b013e31819f12be","article-title":"Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.","volume":"87","author":"Hickson","year":"2009","journal-title":"Transplantation"},{"key":"R197-20231002","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2215\/CJN.03060316","article-title":"Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis.","volume":"11","author":"Francis","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R198-20231002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","article-title":"Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.","volume":"96","author":"Franco Palacios","year":"2013","journal-title":"Transplantation"},{"key":"R199-20231002","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ki.2014.346","article-title":"A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.","volume":"87","author":"Spinale","year":"2015","journal-title":"Kidney Int"},{"key":"R200-20231002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1034\/j.1600-6143.2003.30111.x","article-title":"Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis.","volume":"3","author":"Cibrik","year":"2003","journal-title":"Am J Transplant"},{"key":"R201-20231002","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-6143.2005.00968.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.","volume":"5","author":"Vincenti","year":"2005","journal-title":"Am J Transplant"},{"key":"R202-20231002","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","article-title":"Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.","volume":"15","author":"Ruf","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R203-20231002","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0272-6386(03)00364-0","article-title":"Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.","volume":"41","author":"Bertelli","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R204-20231002","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","article-title":"Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients.","volume":"5","author":"Gohh","year":"2005","journal-title":"Am J Transplant"},{"key":"R205-20231002","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-6143.2007.02021.x","article-title":"Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.","volume":"8","author":"Yabu","year":"2008","journal-title":"Am J Transplant"},{"key":"R206-20231002","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1600-6143.2008.02237.x","article-title":"Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study.","volume":"8","author":"Dabade","year":"2008","journal-title":"Am J Transplant"},{"key":"R207-20231002","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1097\/TP.0000000000001056","article-title":"Recurrent Membranous Nephropathy After Kidney Transplantation: Treatment and Long-Term Implications.","volume":"100","author":"Grupper","year":"2016","journal-title":"Transplantation"},{"key":"R208-20231002","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1111\/j.1600-6143.2009.02851.x","article-title":"Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies.","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"R209-20231002","first-page":"144","article-title":"Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors.","volume":"50","author":"Cosyns","year":"1998","journal-title":"Clin Nephrol"},{"key":"R210-20231002","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/ajt.13133","article-title":"Anti-phospholipase A(2) receptor antibodies in recurrent membranous nephropathy.","volume":"15","author":"Kattah","year":"2015","journal-title":"Am J Transplant"},{"key":"R211-20231002","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/TP.0000000000000630","article-title":"Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.","volume":"99","author":"Quintana","year":"2015","journal-title":"Transplantation"},{"key":"R212-20231002","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/01.ASN.0000071511.35221.B3","article-title":"Rituximab in idiopathic membranous nephropathy: a one-year prospective study.","volume":"14","author":"Ruggenenti","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R213-20231002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1399-3046.2004.00177.x","article-title":"Renal transplantation in patients with IgA mesangial glomerulonephritis.","volume":"8","author":"Ponticelli","year":"2004","journal-title":"Pediatr Transplant"},{"key":"R214-20231002","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/ndt\/gfr664","article-title":"IgA nephropathy recurs early in the graft when assessed by protocol biopsy.","volume":"27","author":"Ortiz","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R215-20231002","first-page":"279","article-title":"Favorable outcome of renal transplantation in patients with IgA nephropathy.","volume":"56","author":"Andresdottir","year":"2001","journal-title":"Clin Nephrol"},{"key":"R216-20231002","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/ndt\/gfs472","article-title":"The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.","volume":"28","author":"Moroni","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R217-20231002","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.transproceed.2005.09.172","article-title":"Recurrence of IgA nephropathy and Henoch-Schonlein purpura after kidney transplantation: risk factors and graft survival.","volume":"37","author":"Soler","year":"2005","journal-title":"Transplant Proc"},{"key":"R218-20231002","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2215\/CJN.00520111","article-title":"Recurrence and graft loss after kidney transplantation for Henoch-Schonlein purpura nephritis: a multicenter analysis.","volume":"6","author":"Kanaan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R219-20231002","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2215\/CJN.01410211","article-title":"Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura.","volume":"6","author":"Samuel","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R220-20231002","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2010.1","article-title":"Recurrent membranoproliferative glomerulonephritis after kidney transplantation.","volume":"77","author":"Lorenz","year":"2010","journal-title":"Kidney Int"},{"key":"R221-20231002","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.ajkd.2010.09.021","article-title":"Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis.","volume":"57","author":"Angelo","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R222-20231002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2215\/CJN.05750710","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft.","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R223-20231002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome.","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R224-20231002","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.","volume":"25","author":"Zand","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R225-20231002","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"key":"R226-20231002","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1681\/ASN.2005020175","article-title":"Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.","volume":"16","author":"Braun","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R227-20231002","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00467-011-2059-7","article-title":"Clinical features and outcomes of 98 children and adults with dense deposit disease.","volume":"27","author":"Lu","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R228-20231002","first-page":"323","article-title":"Renal transplantation in mesangioproliferative glomerulonephritis (MPGN): relationship between the high frquency of recurrent glomerulonephritis and hypocomplementemia.","author":"Berthoux","year":"1975","journal-title":"Kidney Int Suppl"},{"key":"R229-20231002","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.1979.51","article-title":"Recurrence of dense deposits in transplanted kidney: II. Serum complement and nephritic factor profiles.","volume":"15","author":"Leibowitch","year":"1979","journal-title":"Kidney Int"},{"key":"R230-20231002","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.TP.0000053750.59630.83","article-title":"Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare.","volume":"75","author":"Goral","year":"2003","journal-title":"Transplantation"},{"key":"R231-20231002","first-page":"1116","article-title":"Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study.","volume":"7","author":"Nyberg","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"R232-20231002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(96)00074-5","article-title":"End-stage renal disease and systemic lupus erythematosus.","volume":"101","author":"Mojcik","year":"1996","journal-title":"Am J Med"},{"key":"R233-20231002","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.24776","article-title":"Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution.","volume":"60","author":"Burgos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R234-20231002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1681\/ASN.2009101093","article-title":"Recurrence of lupus nephritis after kidney transplantation.","volume":"21","author":"Contreras","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R235-20231002","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/ard.2009.122796","article-title":"Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study.","volume":"69","author":"Norby","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R236-20231002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0049-0172(97)80033-9","article-title":"Outcome of renal transplantation in systemic lupus erythematosus.","volume":"27","author":"Stone","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"R237-20231002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/01.tp.0000235740.56573.c6","article-title":"Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database.","volume":"82","author":"Bunnapradist","year":"2006","journal-title":"Transplantation"},{"key":"R238-20231002","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00007890-199810270-00006","article-title":"Long-term outcome of kidney transplantation in patients with systemic lupus erythematosus: a multicenter study. Groupe Cooperatif de Transplantation d\u2019ile de France.","volume":"66","author":"Grimbert","year":"1998","journal-title":"Transplantation"},{"key":"R239-20231002","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1001\/archinte.1983.00350110067018","article-title":"Renal transplantation in patients with systemic lupus erythematosus.","volume":"143","author":"Mejia","year":"1983","journal-title":"Arch Intern Med"},{"key":"R240-20231002","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00007890-199111000-00009","article-title":"Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature.","volume":"52","author":"Goss","year":"1991","journal-title":"Transplantation"},{"key":"R241-20231002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000167615","article-title":"Renal transplantation in systemic lupus erythematosus: one center\u2019s experience.","volume":"7","author":"Roth","year":"1987","journal-title":"Am J Nephrol"},{"key":"R242-20231002","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1600-6143.2010.03233.x","article-title":"Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies.","volume":"10","author":"Canaud","year":"2010","journal-title":"Am J Transplant"},{"key":"R243-20231002","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00007890-199901150-00015","article-title":"Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients.","volume":"67","author":"Ducloux","year":"1999","journal-title":"Transplantation"},{"key":"R244-20231002","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ndt\/gfx353","article-title":"Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey.","volume":"33","author":"Gauthier","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"R245-20231002","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1600-6143.2007.01904.x","article-title":"The long-term prognosis of renal transplant in patients with systemic vasculitis.","volume":"7","author":"Moroni","year":"2007","journal-title":"Am J Transplant"},{"key":"R246-20231002","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1046\/j.1523-1755.1999.00666.x","article-title":"Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis.","volume":"56","author":"Nachman","year":"1999","journal-title":"Kidney Int"},{"key":"R247-20231002","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/sj.ki.5002244","article-title":"Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression.","volume":"71","author":"Gera","year":"2007","journal-title":"Kidney Int"},{"key":"R248-20231002","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/TP.0b013e31821ab9aa","article-title":"Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience.","volume":"91","author":"Geetha","year":"2011","journal-title":"Transplantation"},{"key":"R249-20231002","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/ndt\/gfp347","article-title":"Renal transplantation in systemic vasculitis: when is it safe?","volume":"24","author":"Little","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R250-20231002","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1016\/S0272-6386(03)00917-X","article-title":"Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation.","volume":"42","author":"Lobbedez","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R251-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP59001","article-title":"Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease.","volume":"59","author":"Deegens","year":"2003","journal-title":"Clin Nephrol"},{"key":"R252-20231002","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/oxfordjournals.ndt.a027889","article-title":"Goodpasture syndrome and end-stage renal failure--to transplant or not to transplant?","volume":"13","author":"Netzer","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R253-20231002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00467-002-0936-9","article-title":"Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.","volume":"17","author":"Ferraris","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"R254-20231002","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/ajt.12297","article-title":"Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.","volume":"13","author":"Alberti","year":"2013","journal-title":"Am J Transplant"},{"key":"R255-20231002","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"R256-20231002","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R257-20231002","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation.","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"R258-20231002","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant"},{"key":"R259-20231002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R260-20231002","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1681\/ASN.2008080906","article-title":"Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.","volume":"20","author":"Saland","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R261-20231002","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1600-6143.2004.00605.x","article-title":"Kidney transplantation for systemic sclerosis improves survival and may modulate disease activity.","volume":"4","author":"Gibney","year":"2004","journal-title":"Am J Transplant"},{"key":"R262-20231002","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/ajkd.2001.24516","article-title":"Relationship between underlying renal disease and renal transplantation outcome.","volume":"37","author":"Bleyer","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R263-20231002","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/tri.12923","article-title":"Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study.","volume":"30","author":"Bertrand","year":"2017","journal-title":"Transpl Int"},{"key":"R264-20231002","doi-asserted-by":"crossref","first-page":"c228","DOI":"10.1159\/000341760","article-title":"Defining the role of renal transplantation in the modern management of multiple myeloma and other plasma cell dyscrasias.","volume":"120","author":"Bansal","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R265-20231002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/10428190601126602","article-title":"Renal failure in multiple myeloma: incidence, correlations, and prognostic significance.","volume":"48","author":"Eleutherakis-Papaiakovou","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R266-20231002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000166684","article-title":"Renal transplantation in light-chain multiple myeloma.","volume":"3","author":"Walker","year":"1983","journal-title":"Am J Nephrol"},{"key":"R267-20231002","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ndt\/11.7.1486","article-title":"Multiple myeloma treatment in dialysis-dependent patients: to transplant or not to transplant?","volume":"11","author":"van Bommel","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R268-20231002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/ndt\/gfp679","article-title":"Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.","volume":"25","author":"Tsakiris","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R269-20231002","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/TP.0b013e31820a3068","article-title":"Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease.","volume":"91","author":"Spitzer","year":"2011","journal-title":"Transplantation"},{"key":"R270-20231002","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1097\/TP.0000000000002449","article-title":"Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma.","volume":"102","author":"Huskey","year":"2018","journal-title":"Transplantation"},{"key":"R271-20231002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease.","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R272-20231002","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10157-013-0812-x","article-title":"Heavy chain deposition disease: an overview.","volume":"17","author":"Oe","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"R273-20231002","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"key":"R274-20231002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2018.09.021","article-title":"Long-term outcome of kidney transplantation in AL amyloidosis.","volume":"95","author":"Angel-Korman","year":"2019","journal-title":"Kidney Int"},{"key":"R275-20231002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0272-6386(03)00676-0","article-title":"Long-term outcome of live donor kidney transplantation for renal amyloidosis.","volume":"42","author":"Sherif","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R276-20231002","first-page":"159","article-title":"Renal transplantation in secondary systemic amyloidosis.","volume":"12","author":"Heering","year":"1998","journal-title":"Clin Transplant"},{"key":"R277-20231002","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1600-6143.2011.03620.x","article-title":"Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study.","volume":"11","author":"Kofman","year":"2011","journal-title":"Am J Transplant"},{"key":"R278-20231002","first-page":"180","article-title":"Fibrillary glomerulonephritis and pulmonary hemorrhage in a patient with renal transplantation.","volume":"43","author":"Calls Ginesta","year":"1995","journal-title":"Clin Nephrol"},{"key":"R279-20231002","first-page":"159","article-title":"Outcome of renal transplantation in fibrillary glomerulonephritis.","volume":"55","author":"Samaniego","year":"2001","journal-title":"Clin Nephrol"},{"key":"R280-20231002","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ki.2008.577","article-title":"Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits.","volume":"75","author":"Czarnecki","year":"2009","journal-title":"Kidney Int"},{"key":"R281-20231002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000440815","article-title":"End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.","volume":"42","author":"Mallett","year":"2015","journal-title":"Am J Nephrol"},{"key":"R282-20231002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ndt\/5.5.332","article-title":"Kidney transplantation in primary oxalosis: data from the EDTA Registry.","volume":"5","author":"Broyer","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"R283-20231002","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/j.1600-6143.2010.03271.x","article-title":"Transplantation outcomes in primary hyperoxaluria.","volume":"10","author":"Bergstralh","year":"2010","journal-title":"Am J Transplant"},{"key":"R284-20231002","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2215\/CJN.07430711","article-title":"Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy.","volume":"7","author":"Harambat","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R285-20231002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF01959482","article-title":"Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1.","volume":"150","author":"Ruder","year":"1990","journal-title":"Eur J Pediatr"},{"key":"R286-20231002","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1399-3046.2008.01049.x","article-title":"Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation.","volume":"13","author":"Malla","year":"2009","journal-title":"Pediatr Transplant"},{"key":"R287-20231002","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1681\/ASN.2016030338","article-title":"An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.","volume":"28","author":"Liebow","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R288-20231002","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mt.2016.50","article-title":"siRNA Therapeutics for Primary Hyperoxaluria: A Beginning.","volume":"24","author":"Milliner","year":"2016","journal-title":"Mol Ther"},{"key":"R289-20231002","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.kint.2016.01.033","article-title":"Controversies and research agenda in nephropathic cystinosis: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference.","volume":"89","author":"Langman","year":"2016","journal-title":"Kidney Int"},{"key":"R290-20231002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/TP.0b013e318191a842","article-title":"Kidney transplant outcomes in patients with Fabry disease.","volume":"87","author":"Shah","year":"2009","journal-title":"Transplantation"},{"key":"R291-20231002","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5301\/jn.5000214","article-title":"Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.","volume":"26","author":"Cybulla","year":"2013","journal-title":"J Nephrol"},{"key":"R292-20231002","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2215\/CJN.05570809","article-title":"Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.","volume":"5","author":"Mignani","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R293-20231002","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0272-6386(87)80027-6","article-title":"Recurrent sickle cell nephropathy in a transplanted kidney.","volume":"10","author":"Miner","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"R294-20231002","first-page":"614610","article-title":"Outcome and challenges of kidney transplant in patients with sickle cell disease.","author":"Okafor","year":"2013","journal-title":"J Transplant"},{"key":"R295-20231002","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00007890-199901270-00018","article-title":"Renal transplantation in end-stage sickle cell nephropathy.","volume":"67","author":"Ojo","year":"1999","journal-title":"Transplantation"},{"key":"R296-20231002","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.transproceed.2012.11.008","article-title":"Sarcoidosis within a renal allograft: a case report and review of the literature.","volume":"45","author":"Mann","year":"2013","journal-title":"Transplant Proc"},{"key":"R297-20231002","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.2215\/CJN.03970510","article-title":"Renal transplantation in patients with sarcoidosis: a French multicenter study.","volume":"5","author":"Aouizerate","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R298-20231002","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/0886022X.2016.1262266","article-title":"Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease.","volume":"39","author":"Kelly","year":"2017","journal-title":"Ren Fail"},{"key":"R299-20231002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","article-title":"Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.","volume":"148","author":"Taylor","year":"2010","journal-title":"Br J Haematol"},{"key":"R300-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R301-20231002","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.transproceed.2004.12.115","article-title":"Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease.","volume":"37","author":"Rozanski","year":"2005","journal-title":"Transplant Proc"},{"key":"R302-20231002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneph.2014.104","article-title":"Renal transplantation in autosomal dominant polycystic kidney disease.","volume":"10","author":"Kanaan","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"R303-20231002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/bjs.1800780313","article-title":"Bilateral nephrectomy before transplantation: indications, surgical approach, morbidity and mortality.","volume":"78","author":"Darby","year":"1991","journal-title":"Br J Surg"},{"key":"R304-20231002","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0090-4295(02)02556-6","article-title":"Pretransplant native nephrectomy in patients with end-stage renal failure: assessment of the role of laparoscopy.","volume":"61","author":"Shoma","year":"2003","journal-title":"Urology"},{"key":"R305-20231002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0090-4295(98)00065-X","article-title":"Outcome of patients with vesicoureteral reflux after renal transplantation: the effect of pretransplantation surgery on posttransplant urinary tract infections.","volume":"51","author":"Erturk","year":"1998","journal-title":"Urology"},{"key":"R306-20231002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S2213-2600(15)00063-6","article-title":"Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies.","volume":"3","author":"Zumla","year":"2015","journal-title":"Lancet Respir Med"},{"key":"R308-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1471-2334-14-333","article-title":"Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis.","volume":"14","author":"Weiss","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R309-20231002","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/TP.0000000000001329","article-title":"Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.","volume":"101","author":"Simkins","year":"2017","journal-title":"Transplantation"},{"key":"R310-20231002","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/pgmj.62.727.359","article-title":"Tuberculosis and renal transplantation--observations from an endemic area of tuberculosis.","volume":"62","author":"Malhotra","year":"1986","journal-title":"Postgrad Med J"},{"key":"R311-20231002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000013600","article-title":"Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients.","volume":"20","author":"Vachharajani","year":"2000","journal-title":"Am J Nephrol"},{"key":"R312-20231002","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/TP.0b013e3182a94a2f","article-title":"Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates.","volume":"97","author":"de Castilla","year":"2014","journal-title":"Transplantation"},{"key":"R313-20231002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.ajkd.2012.07.019","article-title":"Tests for latent tuberculosis in people with ESRD: a systematic review.","volume":"61","author":"Rogerson","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R314-20231002","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5588\/ijtld.11.0259","article-title":"Pre-transplant risk factors for tuberculosis after kidney transplant in an intermediate burden area.","volume":"16","author":"Jung","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"R315-20231002","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"R316-20231002","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s15010-017-1004-5","article-title":"Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates.","volume":"45","author":"Knoll","year":"2017","journal-title":"Infection"},{"key":"R317-20231002","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management.","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"R318-20231002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","article-title":"AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation.","volume":"13","author":"Subramanian","year":"2013","journal-title":"Am J Transplant"},{"key":"R319-20231002","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00784-017-2118-y","article-title":"Oral health in patients with renal disease: a longitudinal study from predialysis to kidney transplantation.","volume":"22","author":"Nylund","year":"2018","journal-title":"Clin Oral Investig"},{"key":"R320-20231002","first-page":"899","article-title":"Oral health in predialysis patients with emphasis on periodontal disease.","volume":"46","author":"Nylund","year":"2015","journal-title":"Quintessence Int"},{"key":"R321-20231002","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s11255-017-1571-5","article-title":"The impact of periodontal disease on physical and psychological domains in long-term hemodialysis patients: a cross-sectional study.","volume":"49","author":"Veisa","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"R322-20231002","first-page":"435","article-title":"Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.","volume":"30","author":"Roland","year":"2016","journal-title":"AIDS"},{"key":"R323-20231002","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ki.2015.74","article-title":"Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV\/HCV-coinfected recipients.","volume":"88","author":"Sawinski","year":"2015","journal-title":"Kidney Int"},{"key":"R324-20231002","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.ASN.0000127987.19470.3A","article-title":"Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression.","volume":"15","author":"Abbott","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R325-20231002","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/TP.0000000000000073","article-title":"Kidney donor risk index (KDRI) fails to predict kidney allograft survival in HIV (+) recipients.","volume":"98","author":"Malat","year":"2014","journal-title":"Transplantation"},{"key":"R326-20231002","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1681\/ASN.2014070726","article-title":"A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.","volume":"26","author":"Locke","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R327-20231002","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa1001197","article-title":"Outcomes of kidney transplantation in HIV-infected recipients.","volume":"363","author":"Stock","year":"2010","journal-title":"N Engl J Med"},{"key":"R328-20231002","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/ajt.13922","article-title":"Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients.","volume":"17","author":"Shelton","year":"2017","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"R330-20231002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ajt.12108","article-title":"AST Infectious Diseases Community of Practice. Viral hepatitis in solid organ transplantation.","volume":"13","author":"Levitsky","year":"2013","journal-title":"Am J Transplant"},{"key":"R331-20231002","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1046\/j.1523-1755.2003.00017.x","article-title":"Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.","volume":"63","author":"Burdick","year":"2003","journal-title":"Kidney Int"},{"key":"R332-20231002","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/01.TP.0000163468.80223.74","article-title":"Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation.","volume":"79","author":"Knoll","year":"2005","journal-title":"Transplantation"},{"key":"R333-20231002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/tid.12065","article-title":"Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers.","volume":"15","author":"Chen","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R334-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"R335-20231002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/ajt.12104","article-title":"Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.","volume":"13","author":"Allen","year":"2013","journal-title":"Am J Transplant"},{"key":"R336-20231002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.15585\/mmwr.mm6706a7","article-title":"QuickStats: Age-Adjusted* Trends in the Prevalence of Herpes Simplex Virus Type 1 (HSV-1) and Herpes Simplex Virus Type 2 (HSV-2) Among Adolescents and Adults Aged 14\u201349 Years - United States, 1999\u20132000 Through 2015\u20132016.","volume":"67","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R337-20231002","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ctr.12752","article-title":"Pre-transplant shedding of BK virus in urine is unrelated to post-transplant viruria and viremia in kidney transplant recipients.","volume":"30","author":"Bicalho","year":"2016","journal-title":"Clin Transplant"},{"key":"R338-20231002","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ctr.12312","article-title":"Role of BK virus infection in end-stage renal disease patients waiting for kidney transplantation--viral replication dynamics from pre- to post-transplant.","volume":"28","author":"Mitterhofer","year":"2014","journal-title":"Clin Transplant"},{"key":"R339-20231002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.TP.0000095898.40458.68","article-title":"Retransplantation in patients with graft loss caused by polyoma virus nephropathy.","volume":"77","author":"Ramos","year":"2004","journal-title":"Transplantation"},{"key":"R340-20231002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-6143.2005.01171.x","article-title":"Retransplantation after polyomavirus-associated nephropathy: just do it?","volume":"6","author":"Hirsch","year":"2006","journal-title":"Am J Transplant"},{"key":"R341-20231002","first-page":"pii","article-title":"HTLV-1-associated myelopathy in a solid organ transplant recipient.","volume":"2016","author":"Montesdeoca Andrade","year":"2016","journal-title":"BMJ Case Rep"},{"key":"R342-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jhbp.345","article-title":"Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan.","volume":"23","author":"Yoshizumi","year":"2016","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R343-20231002","doi-asserted-by":"crossref","first-page":"e2288","DOI":"10.1371\/journal.pntd.0002288","article-title":"Strongyloides stercoralis: Global Distribution and Risk Factors.","volume":"7","author":"Schar","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"R344-20231002","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/598634","article-title":"Chagas\u2019 disease in patients with kidney transplants: 7 years of experience 1989\u20131996.","volume":"29","author":"Riarte","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R345-20231002","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-3062.2012.00731.x","article-title":"Skin lesions, malaise, and heart failure in a renal transplant recipient.","volume":"14","author":"Kocher","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"R346-20231002","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccm.2009.02.011","article-title":"Approach to the diagnosis of the endemic mycoses.","volume":"30","author":"Wheat","year":"2009","journal-title":"Clin Chest Med"},{"key":"R347-20231002","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s40620-017-0443-5","article-title":"The accelerated hepatitis B virus vaccination schedule among hemodialysis patients, does it work? A randomized controlled trial.","volume":"30","author":"Imam","year":"2017","journal-title":"J Nephrol"},{"key":"R348-20231002","doi-asserted-by":"crossref","first-page":"e0133464","DOI":"10.1371\/journal.pone.0133464","article-title":"Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials.","volume":"10","author":"Jin","year":"2015","journal-title":"PLoS One"},{"key":"R349-20231002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ckj\/sfv030","article-title":"The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease.","volume":"8","author":"Vandecasteele","year":"2015","journal-title":"Clin Kidney J"},{"key":"R350-20231002","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2369-13-97","article-title":"Association of response to hepatitis B vaccination and survival in dialysis patients.","volume":"13","author":"Lin","year":"2012","journal-title":"BMC Nephrol"},{"key":"R351-20231002","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/ndt\/gfq094","article-title":"Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial.","volume":"25","author":"Chow","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R352-20231002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1440-1797.2010.01429.x","article-title":"Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India.","volume":"16","author":"Potsangbam","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"R353-20231002","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5414\/CNP68228","article-title":"Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.","volume":"68","author":"Tsouchnikas","year":"2007","journal-title":"Clin Nephrol"},{"key":"R354-20231002","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"R355-20231002","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1442-200X.2009.02816.x","article-title":"Responses in children to measles vaccination associated with perirenal transplantation.","volume":"51","author":"Mori","year":"2009","journal-title":"Pediatr Int"},{"key":"R356-20231002","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.vaccine.2016.11.043","article-title":"Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.","volume":"35","author":"Kho","year":"2017","journal-title":"Vaccine"},{"key":"R357-20231002","first-page":"462","article-title":"Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease.","volume":"62","author":"Tseng","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R358-20231002","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice.","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"R359-20231002","doi-asserted-by":"crossref","first-page":"e13548","DOI":"10.1111\/ctr.13548","article-title":"Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","author":"Malinis","year":"2019","journal-title":"Clin Transplant"},{"key":"R360-20231002","doi-asserted-by":"crossref","first-page":"e13513","DOI":"10.1111\/ctr.13513","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation.","author":"Subramanian","year":"2019","journal-title":"Clin Transplant"},{"key":"R361-20231002","doi-asserted-by":"crossref","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"},{"key":"R362-20231002","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3322\/caac.21557","article-title":"Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening.","volume":"69","author":"Smith","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R363-20231002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"key":"R364-20231002","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/jama.2016.5989","article-title":"Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.","volume":"315","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"R365-20231002","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2018121232","article-title":"One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).","volume":"30","author":"Wong","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R366-20231002","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R367-20231002","first-page":"330","article-title":"Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"R368-20231002","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"R369-20231002","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/ndt\/gfq627","article-title":"Screening for renal cancer in recipients of kidney transplants.","volume":"26","author":"Wong","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R370-20231002","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12885-016-2532-6","article-title":"Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies.","volume":"16","author":"Wong","year":"2016","journal-title":"BMC Cancer"},{"key":"R371-20231002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2369-13-65","article-title":"Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study.","volume":"13","author":"Shebl","year":"2012","journal-title":"BMC Nephrol"},{"key":"R372-20231002","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation.","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"R373-20231002","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(17)30396-3","article-title":"Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial.","volume":"389","author":"Atkin","year":"2017","journal-title":"Lancet"},{"key":"R374-20231002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2215\/CJN.05990616","article-title":"Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD.","volume":"12","author":"Wong","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R375-20231002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1797.2011.01549.x","article-title":"Knowledge, beliefs and attitudes of kidney transplant recipients regarding their risk of cancer.","volume":"17","author":"Williams","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"R376-20231002","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.10090916","article-title":"Beliefs and Attitudes to Bowel Cancer Screening in Patients with CKD: A Semistructured Interview Study.","volume":"12","author":"James","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R377-20231002","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1034\/j.1600-6143.2003.00118.x","article-title":"Screening for prostate, breast and colorectal cancer in renal transplant recipients.","volume":"3","author":"Kiberd","year":"2003","journal-title":"Am J Transplant"},{"key":"R378-20231002","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/ndt\/gfs490","article-title":"Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.","volume":"28","author":"Wong","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R379-20231002","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/TP.0b013e31819d32eb","article-title":"The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.","volume":"87","author":"Wong","year":"2009","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"R380-20231002","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.2215\/CJN.03320807","article-title":"Cancer screening in renal transplant recipients: what is the evidence?","volume":"3","author":"Wong","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R381-20231002","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1053\/j.ajkd.2008.06.015","article-title":"Cost-effectiveness of breast cancer screening in women on dialysis.","volume":"52","author":"Wong","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R382-20231002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines.","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transplant"},{"key":"R383-20231002","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1774-9987.2004.00192.x","article-title":"Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients.","volume":"8","author":"Ishikawa","year":"2004","journal-title":"Ther Apher Dial"},{"key":"R384-20231002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ki.1995.286","article-title":"Screening for acquired cystic kidney disease: a decision analytic perspective.","volume":"48","author":"Sarasin","year":"1995","journal-title":"Kidney Int"},{"key":"R385-20231002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1525-139X.2011.00908.x","article-title":"Should screening for acquired cystic disease and renal malignancy be undertaken in dialysis patients?","volume":"24","author":"Singanamala","year":"2011","journal-title":"Semin Dial"},{"key":"R386-20231002","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.kint.2018.08.032","article-title":"Screening for renal cell carcinoma in dialysis patients.","volume":"94","author":"Liakopoulos","year":"2018","journal-title":"Kidney Int"},{"key":"R387-20231002","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.kint.2018.08.023","article-title":"The authors reply.","volume":"94","author":"Perazella","year":"2018","journal-title":"Kidney Int"},{"key":"R388-20231002","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/TP.0000000000000760","article-title":"Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer.","volume":"99","author":"Viecelli","year":"2015","journal-title":"Transplantation"},{"key":"R389-20231002","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/TP.0000000000001192","article-title":"Outcomes of Solid Organ Transplant Recipients With Preexisting Malignancies in Remission: A Systematic Review and Meta-Analysis.","volume":"101","author":"Acuna","year":"2017","journal-title":"Transplantation"},{"key":"R390-20231002","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1097\/TP.0000000000001659","article-title":"Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.","volume":"101","author":"Dahle","year":"2017","journal-title":"Transplantation"},{"key":"R391-20231002","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0041-1345(00)02698-1","article-title":"Recurrence of cancer after renal transplantation.","volume":"33","author":"Chapman","year":"2001","journal-title":"Transplant Proc"},{"key":"R392-20231002","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.transproceed.2004.12.127","article-title":"Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience.","volume":"37","author":"Woodle","year":"2005","journal-title":"Transplant Proc"},{"key":"R393-20231002","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/ajt.14003","article-title":"The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer.","volume":"17","author":"Mukhtar","year":"2017","journal-title":"Am J Transplant"},{"key":"R394-20231002","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM199903253401207","article-title":"Preoperative pulmonary evaluation.","volume":"340","author":"Smetana","year":"1999","journal-title":"N Engl J Med"},{"key":"R395-20231002","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/bjs.1800740530","article-title":"Prediction of postoperative pulmonary complications in oesophagogastric cancer surgery.","volume":"74","author":"Fan","year":"1987","journal-title":"Br J Surg"},{"key":"R396-20231002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7326\/0003-4819-144-8-200604180-00008","article-title":"Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians.","volume":"144","author":"Qaseem","year":"2006","journal-title":"Ann Intern Med"},{"key":"R397-20231002","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1001\/jama.1983.03340230061032","article-title":"Usefulness of screening chest roentgenograms in preoperative patients.","volume":"250","author":"Rucker","year":"1983","journal-title":"JAMA"},{"key":"R398-20231002","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/BF03009471","article-title":"Value of routine preoperative chest x-rays: a meta-analysis.","volume":"40","author":"Archer","year":"1993","journal-title":"Can J Anaesth"},{"key":"R399-20231002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3322\/caac.21172","article-title":"American Cancer Society lung cancer screening guidelines.","volume":"63","author":"Wender","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"R400-20231002","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1681\/ASN.V114753","article-title":"Cigarette smoking in renal transplant recipients.","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R401-20231002","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1164\/ajrccm.159.4.9807121","article-title":"Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.","volume":"159","author":"Hansen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R402-20231002","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1378\/chest.109.3.741","article-title":"Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory.","volume":"109","author":"Chailleux","year":"1996","journal-title":"Chest"},{"key":"R403-20231002","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/j.ajkd.2007.08.010","article-title":"Evaluation of adult kidney transplant candidates.","volume":"50","author":"Bunnapradist","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R404-20231002","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1681\/ASN.2004090810","article-title":"Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation.","volume":"16","author":"Gill","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R405-20231002","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines.","volume":"64","author":"Fleisher","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R406-20231002","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIR.0b013e31823eb07a","article-title":"Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation.","volume":"126","author":"Lentine","year":"2012","journal-title":"Circulation"},{"key":"R407-20231002","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","article-title":"2014 ESC\/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"R408-20231002","first-page":"CD008691","article-title":"Cardiac testing for coronary artery disease in potential kidney transplant recipients.","author":"Wang","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R409-20231002","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/TP.0000000000000611","article-title":"Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review.","volume":"99","author":"Wang","year":"2015","journal-title":"Transplantation"},{"key":"R410-20231002","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/j.1600-6143.2008.02281.x","article-title":"Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study.","volume":"8","author":"Patel","year":"2008","journal-title":"Am J Transplant"},{"key":"R411-20231002","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.","volume":"301","author":"Young","year":"2009","journal-title":"JAMA"},{"key":"R412-20231002","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.100.10.1043","article-title":"Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.","volume":"100","author":"Lee","year":"1999","journal-title":"Circulation"},{"key":"R413-20231002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ahj.2019.05.008","article-title":"Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study.","volume":"214","author":"Ying","year":"2019","journal-title":"Am Heart J"},{"key":"R414-20231002","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1056\/NEJMoa041905","article-title":"Coronary-artery revascularization before elective major vascular surgery.","volume":"351","author":"McFalls","year":"2004","journal-title":"N Engl J Med"},{"key":"R415-20231002","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2006.11.052","article-title":"A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study.","volume":"49","author":"Poldermans","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R416-20231002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.athoracsur.2007.08.048","article-title":"Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival.","volume":"85","author":"Bechtel","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R417-20231002","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0140-6736(92)93010-K","article-title":"Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure.","volume":"340","author":"Manske","year":"1992","journal-title":"Lancet"},{"key":"R418-20231002","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa041895","article-title":"Perioperative beta-blocker therapy and mortality after major noncardiac surgery.","volume":"353","author":"Lindenauer","year":"2005","journal-title":"N Engl J Med"},{"key":"R419-20231002","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/ALN.0b013e3181f1c061","article-title":"Association of the pattern of use of perioperative beta-blockade and postoperative mortality.","volume":"113","author":"Wallace","year":"2010","journal-title":"Anesthesiology"},{"key":"R420-20231002","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamainternmed.2013.11349","article-title":"Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.","volume":"174","author":"Andersson","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R421-20231002","first-page":"259","article-title":"KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"R422-20231002","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1093\/ndt\/gfp416","article-title":"Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation.","volume":"24","author":"Hurst","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R423-20231002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0735-1097(03)00572-2","article-title":"Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.","volume":"42","author":"Berger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R424-20231002","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2002.125513","article-title":"Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease.","volume":"144","author":"McCullough","year":"2002","journal-title":"Am Heart J"},{"key":"R425-20231002","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"R426-20231002","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/CIR.0000000000000029","article-title":"2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"key":"R427-20231002","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/SLA.0b013e3182125196","article-title":"Risk of surgery following recent myocardial infarction.","volume":"253","author":"Livhits","year":"2011","journal-title":"Ann Surg"},{"key":"R428-20231002","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-156-6-201203200-00007","article-title":"Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis.","volume":"156","author":"Palmer","year":"2012","journal-title":"Ann Int Med"},{"key":"R429-20231002","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.112.102715","article-title":"Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study.","volume":"126","author":"Wijeysundera","year":"2012","journal-title":"Circulation"},{"key":"R430-20231002","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.jacc.2014.09.072","article-title":"The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting.","volume":"64","author":"Holcomb","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R431-20231002","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R432-20231002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ndt\/gfq719","article-title":"Kidney disease in cardiology.","volume":"26","author":"Herzog","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R433-20231002","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/hc1102.100075","article-title":"Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC\/AHA practice guidelines on valve selection be modified?","volume":"105","author":"Herzog","year":"2002","journal-title":"Circulation"},{"key":"R434-20231002","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1681\/ASN.2014111111","article-title":"Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.","volume":"27","author":"Navaneethan","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R435-20231002","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/TP.0b013e31828dbbbe","article-title":"Do echocardiographic parameters predict mortality in patients with end-stage renal disease?","volume":"95","author":"Stallworthy","year":"2013","journal-title":"Transplantation"},{"key":"R436-20231002","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.","volume":"45","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R437-20231002","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/TP.0000000000001043","article-title":"Evaluation and Management of Pulmonary Hypertension in Kidney Transplant Candidates and Recipients: Concepts and Controversies.","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"R438-20231002","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1681\/ASN.2007040503","article-title":"Systolic dysfunction portends increased mortality among those waiting for renal transplant.","volume":"19","author":"de Mattos","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R439-20231002","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"R440-20231002","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2215\/CJN.00050110","article-title":"Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.","volume":"5","author":"Yamada","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R441-20231002","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R442-20231002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","article-title":"Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"42","author":"Vahanian","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"R443-20231002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ndt\/gfs492","article-title":"End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.","volume":"28","author":"Tang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R444-20231002","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2010.03227.x","article-title":"Solid organ transplantation in AL amyloidosis.","volume":"10","author":"Sattianayagam","year":"2010","journal-title":"Am J Transplant"},{"key":"R445-20231002","doi-asserted-by":"crossref","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","article-title":"Updates in cardiac amyloidosis: a review.","volume":"1","author":"Banypersad","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"R446-20231002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ahj.2018.07.023","article-title":"International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.","volume":"205","author":"Bangalore","year":"2018","journal-title":"Am Heart J"},{"key":"R447-20231002","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/1538574416674843","article-title":"Lower Extremity Revascularization in End-Stage Renal Disease.","volume":"50","author":"Jones","year":"2016","journal-title":"Vasc Endovascular Surg"},{"key":"R448-20231002","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/TP.0b013e31827eef36","article-title":"Effect of peripheral vascular disease on kidney allograft outcomes: a study of U.S. Renal data system.","volume":"95","author":"Brar","year":"2013","journal-title":"Transplantation"},{"key":"R449-20231002","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12888","article-title":"Calcification score evaluation in patients listed for renal transplantation.","volume":"31","author":"Kahn","year":"2017","journal-title":"Clin Transplant"},{"key":"R450-20231002","doi-asserted-by":"crossref","first-page":"pii","DOI":"10.1161\/JAHA.116.003339","article-title":"Ankle Brachial Index and Subsequent Cardiovascular Disease Risk in Patients With Chronic Kidney Disease.","volume":"5","author":"Chen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R451-20231002","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MAJ.0b013e3182896a33","article-title":"Subclinical peripheral arterial disease in renal transplantation.","volume":"347","author":"Wu","year":"2014","journal-title":"Am J Med Sci"},{"key":"R452-20231002","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0041-1345(03)00626-2","article-title":"Helical computed tomography angiography is the most efficient test to assess vascular calcifications in the iliac arterial sector in renal transplant candidates.","volume":"35","author":"Andres","year":"2003","journal-title":"Transplant Proc"},{"issue":"Suppl 1","key":"R453-20231002","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/S1743-9191(13)60030-8","article-title":"Treatment of aortoiliac occlusive or dilatative disease concomitant with kidney transplantation: how and when?","volume":"11","author":"Tozzi","year":"2013","journal-title":"Int J Surg"},{"key":"R454-20231002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejvs.2007.09.022","article-title":"Aortoiliac reconstruction with allograft and kidney transplantation as a one-stage procedure: long term results.","volume":"35","author":"Matia","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R455-20231002","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.transproceed.2011.08.023","article-title":"Is severe atherosclerosis in the aortoiliac region a contraindication for kidney transplantation?","volume":"43","author":"Galazka","year":"2011","journal-title":"Transplant Proc"},{"key":"R456-20231002","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.avsg.2010.12.007","article-title":"Outcomes and timing of aortic surgery in renal transplant patients.","volume":"25","author":"Gallagher","year":"2011","journal-title":"Ann Vasc Surg"},{"key":"R457-20231002","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1681\/ASN.2006030201","article-title":"Peripheral arterial disease and renal transplantation.","volume":"17","author":"Snyder","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R458-20231002","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.transproceed.2015.12.080","article-title":"Can Kidney Transplantation Improve Arterial Stiffness in End-Stage Renal Patients?","volume":"48","author":"Ro","year":"2016","journal-title":"Transplant Proc"},{"key":"R459-20231002","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1708538114555154","article-title":"Does kidney transplantation to iliac artery deteriorate ischemia in the ipsilateral lower extremity with peripheral arterial disease?","volume":"23","author":"Northcutt","year":"2015","journal-title":"Vascular"},{"key":"R460-20231002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00007890-200010150-00010","article-title":"Peripheral vascular occlusive disease in renal transplant recipients: risk factors and impact on kidney allograft survival.","volume":"70","author":"Sung","year":"2000","journal-title":"Transplantation"},{"key":"R461-20231002","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.STR.6.5.564","article-title":"A classification and outline of cerebrovascular diseases. II.","volume":"6","year":"1975","journal-title":"Stroke"},{"key":"R462-20231002","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/SLA.0b013e31824c438d","article-title":"Independent preoperative predictors of outcomes in orthopedic and vascular surgery: the influence of time interval between an acute coronary syndrome or stroke and the operation.","volume":"255","author":"Sanders","year":"2012","journal-title":"Ann Surg"},{"key":"R463-20231002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2014.8165","article-title":"Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery.","volume":"312","author":"Jorgensen","year":"2014","journal-title":"JAMA"},{"key":"R464-20231002","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/M14-0530","article-title":"Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.","volume":"161","author":"Jonas","year":"2014","journal-title":"Ann Intern Med"},{"key":"R465-20231002","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/ndt\/gfm766","article-title":"Pre-transplant predictors of cerebrovascular events after kidney transplantation.","volume":"23","author":"Aull-Watschinger","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R466-20231002","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/M14-1333","article-title":"Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"R467-20231002","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/TXD.0000000000000649","article-title":"Evaluation of Carotid Ultrasonography Screening Among Kidney Transplant Candidates: A Single-Center, Retrospective Study.","volume":"3","author":"Rossitter","year":"2017","journal-title":"Transplant Direct"},{"key":"R468-20231002","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2215\/CJN.09731110","article-title":"Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease.","volume":"6","author":"Irazabal","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R469-20231002","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/STROKEAHA.110.578740","article-title":"Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease.","volume":"42","author":"Xu","year":"2011","journal-title":"Stroke"},{"key":"R470-20231002","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1474-4422(11)70109-0","article-title":"Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis.","volume":"10","author":"Vlak","year":"2011","journal-title":"Lancet Neurol"},{"key":"R471-20231002","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3174\/ajnr.A4490","article-title":"Autosomal Dominant Polycystic Kidney Disease and Intracranial Aneurysms: Is There an Increased Risk of Treatment?","volume":"37","author":"Rozenfeld","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"R472-20231002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"R473-20231002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.semnephrol.2015.10.014","article-title":"KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Intracranial Aneurysms.","volume":"35","author":"Lee","year":"2015","journal-title":"Semin Nephrol"},{"key":"R474-20231002","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/01.ASN.0000118527.74850.66","article-title":"Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up.","volume":"15","author":"Schrier","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R475-20231002","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.ejrad.2013.01.024","article-title":"A follow-up study of autosomal dominant polycystic kidney disease with intracranial aneurysms using 3.0 T three-dimensional time-of-flight magnetic resonance angiography.","volume":"82","author":"Jiang","year":"2013","journal-title":"Eur J Radiol"},{"key":"R476-20231002","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1056\/NEJM197105272842102","article-title":"Effects of renal transplantation on uremic neuropathy. A clinical and electrophysiologic study.","volume":"284","author":"Bolton","year":"1971","journal-title":"N Engl J Med"},{"key":"R477-20231002","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1432-2277.2004.tb00479.x","article-title":"Severe gastrointestinal complications after 1,515 adult kidney transplantations.","volume":"17","author":"Sarkio","year":"2004","journal-title":"Transpl Int"},{"key":"R478-20231002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ndt\/gfq401","article-title":"High frequency of ulcers, not associated with Helicobacter pylori, in the stomach in the first year after kidney transplantation.","volume":"26","author":"Telkes","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R479-20231002","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1399-0012.2002.01012.x","article-title":"Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study.","volume":"16","author":"Logan","year":"2002","journal-title":"Clin Transplant"},{"key":"R480-20231002","first-page":"433","article-title":"Incidence, complications, treatment, and outcome of ulcers of the upper gastrointestinal tract after renal transplantation during the cyclosporine era.","volume":"180","author":"Troppmann","year":"1995","journal-title":"J Am Coll Surg"},{"key":"R481-20231002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/MOT.0b013e3283186b6a","article-title":"Helicobacter pylori in solid-organ transplant recipient.","volume":"13","author":"Ueda","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"R482-20231002","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.transproceed.2007.07.095","article-title":"Advantage of eradication therapy for Helicobacter pylori before kidney transplantation in uremic patients.","volume":"39","author":"Cocchiara","year":"2007","journal-title":"Transplant Proc"},{"key":"R483-20231002","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/ndt\/16.10.2053","article-title":"Should Helicobacter pylori infection be treated before kidney transplantation?","volume":"16","author":"Sarkio","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R484-20231002","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.transproceed.2009.02.064","article-title":"Colonic perforation after renal transplantation: risk factor analysis.","volume":"41","author":"Coccolini","year":"2009","journal-title":"Transplant Proc"},{"key":"R485-20231002","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s11605-014-2593-2","article-title":"A systematic review of complicated diverticulitis in post-transplant patients.","volume":"18","author":"Oor","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"R486-20231002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/SLA.0b013e31818e416a","article-title":"Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: a randomized control trial: short-term results of the Sigma Trial.","volume":"249","author":"Klarenbeek","year":"2009","journal-title":"Ann Surg"},{"key":"R487-20231002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000658-199702000-00010","article-title":"Management of severe pancreatitis in renal transplant recipients.","volume":"225","author":"Slakey","year":"1997","journal-title":"Ann Surg"},{"key":"R488-20231002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9610(99)80108-1","article-title":"The utility of prophylactic laparoscopic cholecystectomy in transplant candidates.","volume":"169","author":"Graham","year":"1995","journal-title":"Ann Surg"},{"key":"R489-20231002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00464-004-8817-x","article-title":"Management of asymptomatic cholelithiasis for patients awaiting renal transplantation.","volume":"19","author":"Jackson","year":"2005","journal-title":"Surg Endosc"},{"key":"R490-20231002","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/000313480807400913","article-title":"Role of ultrasound screening for gallbladder disease in pretransplant patients.","volume":"74","author":"Meka","year":"2008","journal-title":"Am Surg"},{"key":"R491-20231002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9610(98)00009-9","article-title":"Prophylactic cholecystectomy is not indicated following renal transplantation.","volume":"175","author":"Melvin","year":"1998","journal-title":"Am J Surg"},{"key":"R492-20231002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/S1807-59322010000400007","article-title":"Cholelithiasis in patients on the kidney transplant waiting list.","volume":"65","author":"Brito","year":"2010","journal-title":"Clinics (Sao Paulo)"},{"key":"R493-20231002","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ndt\/gfl708","article-title":"Complications of gallstone disease in kidney transplantation patients.","volume":"22","author":"Sarkio","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R494-20231002","doi-asserted-by":"crossref","first-page":"e0135807","DOI":"10.1371\/journal.pone.0135807","article-title":"Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.","volume":"10","author":"Schnitzler","year":"2015","journal-title":"PLoS One"},{"key":"R495-20231002","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"R496-20231002","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/jhep.2002.30695","article-title":"Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.","volume":"35","author":"Dvorchik","year":"2002","journal-title":"Hepatology"},{"key":"R497-20231002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R498-20231002","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.3748\/wjg.v20.i13.3525","article-title":"Clinical management of inflammatory bowel disease in the organ recipient.","volume":"20","author":"Indriolo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R499-20231002","doi-asserted-by":"crossref","first-page":"e5108","DOI":"10.1097\/MD.0000000000005108","article-title":"Anti-TNFalpha therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.","volume":"95","author":"Garrouste","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R500-20231002","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MOG.0000000000000448","article-title":"Updates in colorectal cancer screening in inflammatory bowel disease.","volume":"34","author":"Clarke","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"R501-20231002","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"R502-20231002","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"key":"R503-20231002","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.gastrohep.2018.07.012","article-title":"Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update.","volume":"41","author":"Cubiella","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"R504-20231002","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK).","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"key":"R505-20231002","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1399-0012.2011.01581.x","article-title":"Renal allograft loss in the first post-operative month: causes and consequences.","volume":"26","author":"Phelan","year":"2012","journal-title":"Clin Transplant"},{"key":"R506-20231002","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.TP.0000107185.50838.EE","article-title":"Thrombophilia and thrombotic problems in renal transplant patients.","volume":"77","author":"Kujovich","year":"2004","journal-title":"Transplantation"},{"key":"R507-20231002","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199708270-00010","article-title":"The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients.","volume":"64","author":"Irish","year":"1997","journal-title":"Transplantation"},{"key":"R508-20231002","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/00007890-200004150-00023","article-title":"Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study.","volume":"69","author":"Vaidya","year":"2000","journal-title":"Transplantation"},{"key":"R509-20231002","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/00007890-200109270-00016","article-title":"Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis.","volume":"72","author":"Friedman","year":"2001","journal-title":"Transplantation"},{"key":"R510-20231002","first-page":"141","article-title":"Protective effect of heparin and aspirin against vascular thrombosis in pediatric kidney transplants.","volume":"6","author":"Esfandiar","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"R511-20231002","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5414\/CNP74351","article-title":"A single-center experience of preemptive anticoagulation for patients with risk factors for allograft thrombosis in renal transplantation.","volume":"74","author":"Murashima","year":"2010","journal-title":"Clin Nephrol"},{"key":"R512-20231002","doi-asserted-by":"crossref","first-page":"620","DOI":"10.5500\/wjt.v6.i4.620","article-title":"Organ transplantation and drug eluting stents: Perioperative challenges.","volume":"6","author":"Dalal","year":"2016","journal-title":"World J Transplant"},{"key":"R513-20231002","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ejcts\/ezu366","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).","volume":"46","author":"Kolh","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"R514-20231002","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"R515-20231002","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"R516-20231002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"R517-20231002","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/ajt.14731","article-title":"Plasma cell diseases and organ transplant: A comprehensive review.","volume":"18","author":"Cowan","year":"2018","journal-title":"Am J Transplant"},{"key":"R518-20231002","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1097\/TP.0000000000001884","article-title":"Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.","volume":"101","author":"Alfano","year":"2017","journal-title":"Transplantation"},{"key":"R519-20231002","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1681\/ASN.2011060623","article-title":"Effect of risedronate on bone in renal transplant recipients.","volume":"23","author":"Coco","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R520-20231002","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1523-1755.2003.00816.x","article-title":"Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.","volume":"63","author":"Haas","year":"2003","journal-title":"Kidney Int"},{"key":"R521-20231002","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00198-017-4065-5","article-title":"Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.","volume":"28","author":"Perez-Saez","year":"2017","journal-title":"Osteoporos Int"},{"key":"R522-20231002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/TP.0000000000000808","article-title":"Fracture Incidence in Adult Kidney Transplant Recipients.","volume":"100","author":"Naylor","year":"2016","journal-title":"Transplantation"},{"key":"R523-20231002","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/TP.0b013e31828eead8","article-title":"Fracture risk in kidney transplant recipients: a systematic review.","volume":"95","author":"Naylor","year":"2013","journal-title":"Transplantation"},{"key":"R524-20231002","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1097\/TP.0b013e3181a6bbda","article-title":"Risk of fractures after renal transplantation in the United States.","volume":"87","author":"Nikkel","year":"2009","journal-title":"Transplantation"},{"key":"R525-20231002","first-page":"CD005015","article-title":"Interventions for preventing bone disease in kidney transplant recipients.","author":"Palmer","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R526-20231002","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2215\/CJN.11371015","article-title":"Bone Disease after Kidney Transplantation.","volume":"11","author":"Bouquegneau","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R527-20231002","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R528-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD).","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"R529-20231002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.surg.2016.10.003","article-title":"Parathyroidectomy prior to kidney transplant decreases graft failure.","volume":"161","author":"Callender","year":"2017","journal-title":"Surgery"},{"key":"R530-20231002","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ctr.12099","article-title":"Impact of post-kidney transplant parathyroidectomy on allograft function.","volume":"27","author":"Parikh","year":"2013","journal-title":"Clin Transplant"},{"key":"R531-20231002","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","article-title":"A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.","volume":"27","author":"Cruzado","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R532-20231002","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/ctr.12622","article-title":"Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case report.","volume":"29","author":"Hod","year":"2015","journal-title":"Clin Transplant"},{"key":"R533-20231002","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1525-139X.2011.00911.x","article-title":"Should teriparatide ever be used for adynamic bone disease?","volume":"24","author":"Cejka","year":"2011","journal-title":"Semin Dial"},{"key":"R534-20231002","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1111\/trf.12727","article-title":"Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.","volume":"54","author":"De Clippel","year":"2014","journal-title":"Transfusion"},{"key":"R535-20231002","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318271d776","article-title":"Effects of HLA-matched blood transfusion for patients awaiting renal transplantation.","volume":"94","author":"Magee","year":"2012","journal-title":"Transplantation"},{"key":"R536-20231002","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/tme.12157","article-title":"Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.","volume":"24","author":"Jia","year":"2014","journal-title":"Transfus Med"},{"key":"R537-20231002","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/ajt.12048","article-title":"Frequency and determinants of pregnancy-induced child-specific sensitization.","volume":"13","author":"Honger","year":"2013","journal-title":"Am J Transplant"},{"key":"R538-20231002","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1111\/ajt.13508","article-title":"Predicted Indirectly Recognizable HLA Epitopes Presented by HLA-DRB1 Are Related to HLA Antibody Formation During Pregnancy.","volume":"15","author":"Geneugelijk","year":"2015","journal-title":"Am J Transplant"},{"key":"R539-20231002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1399-0039.2008.01067.x","article-title":"Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.","volume":"72","author":"Arnold","year":"2008","journal-title":"Tissue Antigens"},{"key":"R540-20231002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1399-0039.2005.00382.x","article-title":"Anti-HLA class II antibodies in kidney retransplant patients.","volume":"65","author":"Arnold","year":"2005","journal-title":"Tissue Antigens"},{"key":"R541-20231002","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.humimm.2011.02.018","article-title":"Human leukocyte antigen sensitization after transplant loss: timing of antibody detection and implications for prevention.","volume":"72","author":"Scornik","year":"2011","journal-title":"Hum Immunol"},{"key":"R542-20231002","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.transproceed.2011.12.049","article-title":"Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.","volume":"44","author":"Hyun","year":"2012","journal-title":"Transplant Proc"},{"key":"R543-20231002","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e318288ca14","article-title":"The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients.","volume":"95","author":"Gralla","year":"2013","journal-title":"Transplantation"},{"key":"R544-20231002","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ki.2015.205","article-title":"Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.","volume":"88","author":"Lucia","year":"2015","journal-title":"Kidney Int"},{"key":"R545-20231002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2249.2001.01497.x","article-title":"Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals.","volume":"124","author":"Mulder","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"R546-20231002","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1034\/j.1600-6143.2003.00132.x","article-title":"Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients.","volume":"3","author":"Hricik","year":"2003","journal-title":"Am J Transplant"},{"key":"R547-20231002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/IR:29:1-3:041","article-title":"Evolution of HLA antibody detection: technology emulating biology.","volume":"29","author":"Bray","year":"2004","journal-title":"Immunol Res"},{"key":"R548-20231002","first-page":"87","article-title":"Solid phase HLA antibody detection technology--challenges in interpretation.","volume":"76","author":"Tait","year":"2010","journal-title":"Tissue Antigens"},{"key":"R549-20231002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-62703-493-7_6","article-title":"Transplantation of the sensitized patient: histocompatibility testing.","volume":"1034","author":"Montgomery","year":"2013","journal-title":"Methods Mol Biol"},{"key":"R550-20231002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/TP.0000000000000821","article-title":"Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.","volume":"100","author":"Bachelet","year":"2016","journal-title":"Transplantation"},{"key":"R551-20231002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.humimm.2014.04.001","article-title":"Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.","volume":"75","author":"Mierzejewska","year":"2014","journal-title":"Hum Immunol"},{"key":"R552-20231002","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.humimm.2014.02.008","article-title":"Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report.","volume":"75","author":"Cippa","year":"2014","journal-title":"Hum Immunol"},{"key":"R553-20231002","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/j.1600-6143.2012.04172.x","article-title":"Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation.","volume":"12","author":"Jolly","year":"2012","journal-title":"Am J Transplant"},{"key":"R554-20231002","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1399-0039.2009.01428.x","article-title":"HLA-DP antibodies before and after renal transplantation.","volume":"75","author":"Billen","year":"2010","journal-title":"Tissue Antigens"},{"key":"R555-20231002","first-page":"159","article-title":"Flow cytometry PRA, a new test that is highly correlated with graft survival.","volume":"6","author":"Cicciarelli","year":"1992","journal-title":"Clin Transplant"},{"key":"R556-20231002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00007890-200301150-00008","article-title":"Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.","volume":"75","author":"Pei","year":"2003","journal-title":"Transplantation"},{"key":"R557-20231002","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12026-009-8154-1","article-title":"Immunogenetics and immunology in transplantation.","volume":"47","author":"Zachary","year":"2010","journal-title":"Immunol Res"},{"key":"R558-20231002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.humimm.2009.05.001","article-title":"Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.","volume":"70","author":"Taylor","year":"2009","journal-title":"Hum Immunol"},{"key":"R559-20231002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-61779-842-9_17","article-title":"HLA antibody detection and characterization by solid phase immunoassays: methods and pitfalls.","volume":"882","author":"Zachary","year":"2012","journal-title":"Methods Mol Biol"},{"key":"R560-20231002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/bmb\/ldu005","article-title":"Detection of donor-specific antibodies in kidney transplantation.","volume":"110","author":"Haarberg","year":"2014","journal-title":"Br Med Bull"},{"key":"R561-20231002","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0198-8859(99)00121-4","article-title":"Flow cytometric detection of HLA antibodies using a spectrum of microbeads.","volume":"60","author":"Pei","year":"1999","journal-title":"Hum Immunol"},{"key":"R562-20231002","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0198-8859(98)00020-2","article-title":"Simultaneous HLA Class I and Class II antibodies screening with flow cytometry.","volume":"59","author":"Pei","year":"1998","journal-title":"Hum Immunol"},{"key":"R563-20231002","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males.","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"R564-20231002","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.humimm.2013.06.035","article-title":"Antibodies against denatured HLA class II molecules detected in luminex-single antigen assay.","volume":"74","author":"Grenzi","year":"2013","journal-title":"Hum Immunol"},{"key":"R565-20231002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA): the new measure of sensitization for transplant candidates.","volume":"10","author":"Cecka","year":"2010","journal-title":"Am J Transplant"},{"key":"R566-20231002","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1111\/ajt.13355","article-title":"cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.","volume":"15","author":"Tinckam","year":"2015","journal-title":"Am J Transplant"},{"key":"R567-20231002","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.trim.2007.10.001","article-title":"Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.","volume":"18","author":"Duquesnoy","year":"2008","journal-title":"Transpl Immunol"},{"key":"R568-20231002","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.humimm.2007.10.013","article-title":"DP reactive antibody in a zero mismatch renal transplant pair.","volume":"68","author":"Vaidya","year":"2007","journal-title":"Hum Immunol"},{"key":"R569-20231002","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"R570-20231002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajt.12968","article-title":"HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.","volume":"15","author":"Sapir-Pichhadze","year":"2015","journal-title":"Am J Transplant"},{"key":"R571-20231002","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/ajt.13167","article-title":"Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?","volume":"15","author":"Duquesnoy","year":"2015","journal-title":"Am J Transplant"},{"issue":"s11","key":"R572-20231002","first-page":"488","article-title":"Allele-specific HLA alloantibodies: Implications for organ allocation. [Abstract 1306]","volume":"5","author":"Bray","year":"2005","journal-title":"Am J Transplant"},{"key":"R573-20231002","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"R574-20231002","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1681\/ASN.2014121234","article-title":"Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.","volume":"26","author":"Hricik","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R575-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R576-20231002","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trim.2013.05.002","article-title":"Probability of deceased donor kidney transplantation based on % PRA.","volume":"28","author":"Bostock","year":"2013","journal-title":"Transpl Immunol"},{"key":"R577-20231002","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.suc.2013.08.007","article-title":"The kidney allocation system.","volume":"93","author":"Friedewald","year":"2013","journal-title":"Surg Clin North Am"},{"key":"R578-20231002","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000129260.86766.67","article-title":"The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome.","volume":"78","author":"Claas","year":"2004","journal-title":"Transplantation"},{"key":"R579-20231002","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","article-title":"Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.","volume":"11","author":"Cecka","year":"2011","journal-title":"Am J Transplant"},{"key":"R580-20231002","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MOT.0b013e3283489910","article-title":"The calculated panel reactive antibody policy: an advancement improving organ allocation.","volume":"16","author":"Leffell","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"R581-20231002","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1681\/ASN.2014090894","article-title":"Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates.","volume":"27","author":"Sapir-Pichhadze","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R582-20231002","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/tri.12533","article-title":"Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients.","volume":"28","author":"Huber","year":"2015","journal-title":"Transpl Int"},{"key":"R583-20231002","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/ajt.14247","article-title":"Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.","volume":"17","author":"Wehmeier","year":"2017","journal-title":"Am J Transplant"},{"key":"R584-20231002","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations.","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"R585-20231002","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.","volume":"43","author":"Gonzalez-Galarza","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R586-20231002","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000368056","article-title":"Allele frequencies database.","volume":"41","author":"Takeshita","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"R588-20231002","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"R589-20231002","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"R590-20231002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TP.0b013e31818bd790","article-title":"Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.","volume":"87","author":"Alvarez-Marquez","year":"2009","journal-title":"Transplantation"},{"key":"R591-20231002","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-6143.2006.01644.x","article-title":"Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival.","volume":"7","author":"Terasaki","year":"2007","journal-title":"Am J Transplant"},{"key":"R592-20231002","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection.","volume":"357","author":"Zou","year":"2007","journal-title":"N Engl J Med"},{"key":"R593-20231002","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.humimm.2006.02.007","article-title":"Frequency of MIC antibody in rejected renal transplant patients without HLA antibody.","volume":"67","author":"Mizutani","year":"2006","journal-title":"Hum Immunol"},{"key":"R594-20231002","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/1529-0131(200107)44:7<1484::AID-ART269>3.0.CO;2-Q","article-title":"Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications.","volume":"44","author":"Praprotnik","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R595-20231002","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.humimm.2013.06.007","article-title":"A prospective study evaluating the role of donor-specific anti-endothelial crossmatch (XM-ONE assay) in predicting living donor kidney transplant outcome.","volume":"74","author":"Zitzner","year":"2013","journal-title":"Hum Immunol"},{"key":"R596-20231002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.transproceed.2010.12.040","article-title":"XM-ONE detection of endothelium cell antibodies identifies a subgroup of HLA-antibody negative patients undergoing acute rejection.","volume":"43","author":"Xavier","year":"2011","journal-title":"Transplant Proc"},{"key":"R597-20231002","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1600-6143.2005.01016.x","article-title":"Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure.","volume":"5","author":"Mizutani","year":"2005","journal-title":"Am J Transplant"},{"key":"R598-20231002","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/TP.0000000000000699","article-title":"C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.","volume":"99","author":"Yell","year":"2015","journal-title":"Transplantation"},{"key":"R599-20231002","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure.","volume":"12","author":"Otten","year":"2012","journal-title":"Am J Transplant"},{"key":"R600-20231002","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trim.2013.07.002","article-title":"Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?","volume":"29","author":"Crespo","year":"2013","journal-title":"Transpl Immunol"},{"key":"R601-20231002","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.humimm.2013.01.008","article-title":"Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response.","volume":"74","author":"Lowe","year":"2013","journal-title":"Hum Immunol"},{"key":"R602-20231002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R603-20231002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/tri.12206","article-title":"Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1\/IgG3 to noncomplement fixing IgG2\/IgG4 anti-HLA alloantibodies.","volume":"27","author":"Arnold","year":"2014","journal-title":"Transpl Int"},{"key":"R604-20231002","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.","volume":"27","author":"Guidicelli","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R605-20231002","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1111\/j.1600-6143.2012.04251.x","article-title":"Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.","volume":"12","author":"Ginevri","year":"2012","journal-title":"Am J Transplant"},{"key":"R606-20231002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ajt.14015","article-title":"Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival.","volume":"17","author":"Wiebe","year":"2017","journal-title":"Am J Transplant"},{"key":"R607-20231002","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.13700","article-title":"Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients.","volume":"16","author":"Comoli","year":"2016","journal-title":"Am J Transplant"},{"key":"R608-20231002","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival.","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"R609-20231002","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information.","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"key":"R610-20231002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.TP.0000128516.82593.47","article-title":"Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.","volume":"78","author":"Gloor","year":"2004","journal-title":"Transplantation"},{"key":"R611-20231002","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1600-6143.2010.03312.x","article-title":"The histology of solitary renal allografts at 1 and 5 years after transplantation.","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"R612-20231002","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation.","volume":"10","author":"Gloor","year":"2010","journal-title":"Am J Transplant"},{"key":"R613-20231002","first-page":"699","article-title":"Paired kidney donations to expand the living donor pool.","volume":"22","author":"Ferrari","year":"2009","journal-title":"J Nephrol"},{"key":"R614-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-6143.2010.03313.x","article-title":"Virtual crossmatch approach to maximize matching in paired kidney donation.","volume":"11","author":"Ferrari","year":"2011","journal-title":"Am J Transplant"},{"key":"R615-20231002","doi-asserted-by":"crossref","first-page":"700","DOI":"10.5694\/j.1326-5377.2009.tb02642.x","article-title":"Paired kidney donations to expand the living donor pool: the Western Australian experience.","volume":"190","author":"Ferrari","year":"2009","journal-title":"Med J Aust"},{"key":"R616-20231002","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.transproceed.2007.02.081","article-title":"Five years of single-center experience with paired kidney exchange transplantation.","volume":"39","author":"Lucan","year":"2007","journal-title":"Transplant Proc"},{"key":"R617-20231002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(06)69115-0","article-title":"Domino paired kidney donation: a strategy to make best use of live non-directed donation.","volume":"368","author":"Montgomery","year":"2006","journal-title":"Lancet"},{"key":"R618-20231002","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1600-6143.2010.03034.x","article-title":"Altruistic donor triggered domino-paired kidney donation for unsuccessful couples from the kidney-exchange program.","volume":"10","author":"Roodnat","year":"2010","journal-title":"Am J Transplant"},{"key":"R619-20231002","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/j.1600-6143.2006.01515.x","article-title":"Utilizing list exchange and nondirected donation through \u2018chain\u2019 paired kidney donations.","volume":"6","author":"Roth","year":"2006","journal-title":"Am J Transplant"},{"key":"R620-20231002","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1399-0012.2006.00621.x","article-title":"Paired kidney donation by shipment of living donor kidneys.","volume":"21","author":"Waki","year":"2007","journal-title":"Clin Transplant"},{"key":"R621-20231002","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/ndt\/gfu309","article-title":"Kidney paired donation: principles, protocols and programs.","volume":"30","author":"Ferrari","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R622-20231002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(16)31595-1","article-title":"Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis.","volume":"389","author":"Manook","year":"2017","journal-title":"Lancet"},{"key":"R623-20231002","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study.","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"R624-20231002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival.","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"R625-20231002","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome.","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R626-20231002","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-6143.2009.03001.x","article-title":"Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols.","volume":"10","author":"Montgomery","year":"2010","journal-title":"Am J Transplant"},{"key":"R627-20231002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jca.20206","article-title":"Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts.","volume":"24","author":"Sivakumaran","year":"2009","journal-title":"J Clin Apher"},{"key":"R628-20231002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation.","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"R629-20231002","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"R630-20231002","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"R631-20231002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization.","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant"},{"key":"R632-20231002","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.tp.0000269615.91036.52","article-title":"The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.","volume":"84","author":"Gloor","year":"2007","journal-title":"Transplantation"},{"key":"R633-20231002","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"key":"R634-20231002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T10:35:53Z","timestamp":1722681353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":621,"journal-issue":{"issue":"4S1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003136","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}